independent continuant;influvac;influvac is an influenza virus vaccine that is manufactured by solvay pharma.
independent continuant;pmma vaccine adjuvant;a synthetic vaccine adjuvant made from the emulsion polymerization of methyl methacrylate.
independent continuant;as01b vaccine adjuvant;3-o-desacyl-4 -monophosphoryl lipid a (mpl) from salmonella minnesota and a saponin molecule (qs-21) purified from plant extract quillaja saponaria molina, combined in a liposomal formulation consisting of dioleoyl phosphatidylcholine (dopc) and cholesterol in phosphate-buffered saline solution.
independent continuant;eolarix;a measles-rubella vaccine that is live attenuated and manufactured by glaxosmithkline biologicals.
independent continuant;vaccine;a vaccine is a processed material with the function that when administered, it prevents or ameliorates a disorder in a target organism by inducing or modifying adaptive immune responses specific to the antigens in the vaccine.
independent continuant;transmissible gastroenteritis virus vaccine;viral vaccine that is used to protect against transmissible gastroenteritis virus infection
independent continuant;coviran barakat;a sars-cov-2 inactivated vaccine by shifa pharmed
independent continuant;vibrio cholerae gene;a bacterial gene that is from vibrio cholerae.
independent continuant;subtenon route;a route of administration that is through the membrane covering the muscles and nerves at the back of the eyeball
independent continuant;corvax12;a sars-cov-2 dna vaccine developed by providence health & services.
independent continuant;fowl pox vaccine;a viral vaccine that is used to protect against fowl pox virus infection
independent continuant;acmnpv vector;an adenovirus vaccine vector that contains a deletion of the gp64 gene. as a result of the deletion, this vector is unable to propagate infection from cell to cell, and this defect results from both a severe reduction in the production of budded virions and the absence of gp64 on virions. 
independent continuant;staphylococcus aureus phage lysate vaccine;a s. aureus vaccine that uses the bacterial phage lysate as the protective antigen. 
independent continuant;authorized covid-19 vaccine;a covid-19 vaccine that is authorized for emergent use, which is typically authorized based on an emergency use authorization (eua).
independent continuant;hepatitis b vaccine foreign to usa;a hepatitis b vaccine manufactured outside of the u.s.
independent continuant;t-vant vaccine adjuvant;t-vant is a vaccine adjuant that is derived from salmonella enterica serovar typhimurium and is able to induce th1/th2/th17 immune responses through the mechanism of action of tlr4, inflammasome, and dc activation.
independent continuant;fluzone high-dose;an influenza vaccine that is similar to fluzone but has high dose. 
independent continuant;qazvac;a sars-cov-2 inactivated vaccine manufactured by the research institute for biological safety problems (republic of kazakhstan)
independent continuant;autogenous bacterin vaccine;a bacterial vaccine that uses bacterin from a bacterial strain isolated from a herd with a purpose to generate hard-specific vaccine. 
independent continuant;measles-mumps vaccine;a measles virus vaccine that also protects against infection with mumps virus.
independent continuant;cmv vaccine vector;a herpesvirus vaccine vector that uses a cmv virus strain
independent continuant;pgfp dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pgfp. this plasmid is 3300 base pairs in length and contains a lac promoter and an ampicillin resistance gene.
independent continuant;ino-4800;a dna vaccine that expresses s protein from the pgx9501 vector
independent continuant;schistosoma mansoni vaccine;a protozoan vaccine against schistosoma mansoni
independent continuant;sars tpa-s dna vaccine;a sars dna vaccine that is made from tpa-optimize800 dna with sars-cov s protein
independent continuant;nkcmvint dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label nkcmvint.
independent continuant;yersinia pestis gene;a bacterial gene that is from yersinia pestis.
independent continuant;imovax id;a vaccine used to develop immunity to rabies.
independent continuant;piscirickettsia salmonis vaccine;bacterial vaccine that is used to protect against piscirickettsia salmonis infection
independent continuant;lipo-5;lipo-5 is a therapeutic hiv vaccine made up of lipopeptides, study names: vri02/anrs 149 light. nct01492985
independent continuant;recombinant homologous vector vaccine;a recombinant vector vaccine that uses a homologous vector, i.e., when the target species of the vaccine is a natural host for the vector.
independent continuant;vb10.2129;a sars-cov-2 dna vaccine developed by vaccibody as encoding the receptor-binding domain
independent continuant;specol vaccine adjuvant;specon is an emulsion vaccine adjuvant that is a water-in-oil emulsion that is used as an adjuvant and has immunostimulating properties similar to freund's complete adjuvant (fca).
independent continuant;subunit vaccine;a vaccine that is composed of a purified protein(s) or other antigenic determinant(s) from a disease-causing organism. a subunit vaccine does not include pathogen nucleic acids. the subunits have less risk of causing adverse reactions.
independent continuant;sars ma-exon vaccine;a sars recombinant vector vaccine that is made from of the highly attenuated modified vaccinia virus ankara (mva) containing the gene encoding full-length sars-cov s
independent continuant;osvid-19;a sars-cov-2 inactivated vaccine developed by osve pharmaceutical company.
independent continuant;sublingual route;an oral route of administration that is underneath the tongue.
independent continuant;zymosan vaccine adjuvant;polysaccharide prepared from the cell wall of saccaromyces cerevisiae (bakers' yeast)
independent continuant;pgt146-mil-12 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pgt146-mil-12.
independent continuant;diphtheria-tetanus vaccine;a corynebacterium diphtheriae vaccine that also protect against infection with clostridium tetani.
independent continuant;chlamydophila psittaci vaccine;a chlamydia bacterial vaccine against chlamydophila psittaci infection
independent continuant;incomplete freunds adjuvant;a freud's adjuvant that does not contain the mycobacterial components.
independent continuant;hepatitis a virus vaccine;a viral vaccine that protects against infection with hepatitis a virus.
independent continuant;protozoan vaccine;a vaccine that protects against some protozoan disease.
independent continuant;arct-021;a sars-cov-2 investigational vaccine comprising a self-replicating (replicon) mrna that encodes for the prefusion spike protein of 2019-ncov formulated in a lipid nanoparticle
independent continuant;bacillus vaccine;a vaccine that is used against an infection by a pathogen under bacillus.
independent continuant;caprine herpesvirus 1 vaccine;a viral vaccine that protects against infection with caprine herpesvirus 1
independent continuant;phcmv1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label phcmv1. this plasmid is 4200 base pairs long, has a cmv promoter, contains kanamycin and neomycin antibiotics resistance genes, and is manufactured by genlantis. 
independent continuant;bcg vaccine;bcg vaccine is a mycobacterium tuberculosis vaccine that is a live attenuated strain of mycobacterium bovis (bacillus calmette guerin. bcg).
independent continuant;t. cruzi dna vaccine encoding tsa-1;a t. cruzi dna vaccine that uses a dna plasmid expressing t. cruzi tsa-1 protein.
independent continuant;bordetella bronchiseptica vaccine;a bordetella bacterial vaccine that is used to protect against bordetella bronchiseptica infection
independent continuant;inactivated bacterial vaccine;a bacterial vaccine that uses inactivated bacterial organism. 
independent continuant;vr10551 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vr10551. this plasmid contains a human cytomegalovirus immediate early 1 promoter, a kanamycin resistance gene, intron a and a modified rabbit b-globin terminator.
independent continuant;toxoid;is a bacterial toxin (usually an exotoxin) whose toxicity has been weakened or suppressed either by chemical (formalin) or heat treatment, while other properties, typically immunogenicity, are maintained.
independent continuant;covigenix vax-001;a prophylactic plasmid dna vaccine for sars cov-2 by entos pharmaceuticals
independent continuant;dna and ad5/35 vector expressing hiv gp160 protein;a vaccine combination that includes a dna vaccine and a replication-defective chimeric ad5 vector with the ad35 fiber (ad5/35) that express the same codon-optimized siv gag gene. the dna vaccine is used for priming, and the ad5/35 vaccine is used for boosting. pmid: 16079886.
independent continuant;spfn;a sars-cov-2 protein subunit vaccine manufactured by walter reed army institute of research
independent continuant;crl1005 vaccine adjuvant;a synthetic vaccine adjuvant that is a copolymer (crl1005), based on a 12 kda polyoxypropylene (pop) core with 5% poe.
independent continuant;bay r1005 vaccine adjuvant;a synthetic vaccine adjuvant that is bay r1005 (n-(2-deoxy-2-l-leucylamino -d-glucopyranosyl)-n-octadecyldodecanoylamide hydroacetate ).
independent continuant;salmonella typhimurium sl3261 vaccine vector;a bacterial vaccine vector using a live attenuated salmonella enterica strain sl3261. 
independent continuant;corynebacterium pseudotuberculosis vaccine vector;a bacterial vaccine vector that uses a corynebacterium pseudotuberculosis strain as the vaccine vector
independent continuant;sars mva/s vaccine;a sars recombinant vector vaccine made from a recombinant form of the highly attenuated modified vaccinia virus ankara (mva) containing the gene encoding full-length sars-cov s
independent continuant;b7-2 vaccine adjuvant;a cytokine vaccine adjuvant that includes b7-2.
independent continuant;therapeutic vaccine;a vaccine that is used for treatment for a disease.
independent continuant;bovine viral diarrhea virus 1 vaccine;viral vaccine that is used to protect against bovine viral diarrhea virus 1 infection
independent continuant;recombinant sars dna spike protein vaccine;a sars dna vaccine made from rdna-expressed ectodomain of the s protein.
independent continuant;staphylococcus aureus vaccine;a bacterial vaccine that protects against infection with staphylococcus aureus.
independent continuant;burkholderia pseudomallei gene;a bacterial gene that is from burkholderia pseudomallei.
independent continuant;tetracoq;an adsorbed diphtheria, tetanus, pertussis and inactivated poliomyelitis vaccine.
independent continuant;v590;a sars-cov-2 vaccine that uses a recombinant vesicular stomatitis virus (rvsv) platform, and is made by merck. development of the vaccine was discontinued on january 25, 2021.
independent continuant;viral-like-particle s-mhv sars vaccine;a sars vlp vaccine made from the sars-cov spike protein (s) and the nucleocapsid (n), envelope (e) and membrane (m) proteins from mouse hepatitis coronavirus (mhv)
independent continuant;psw3891 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psw3891. this plasmid contains a cmv promoter.
independent continuant;priorix;a mmr vaccine that is manufactured by glaxosmithkline biologicals.
independent continuant;porcine respiratory and reproductive syndrome virus gene;a viral gene that is from porcine respiratory and reproductive syndrome virus.
independent continuant;aluminum vaccine adjuvant;a mineral salt vaccine adjuvant that is composed of aluminum salt.
independent continuant;chulacov19;a sars-cov-2 mrna vaccine manufactured by chulalongkorn university
independent continuant;feline herpesvirus 1 gene;a viral gene that is from feline herpesvirus 1.
independent continuant;gm-csf vaccine adjuvant;a cytokine vaccine adjuvant that includes gm-csf.
independent continuant;murid herpesvirus 1 vaccine;a viral vaccine that protects against infection with murine cytomegalovirus (or called murid herpesvirus 1).
independent continuant;psittacid herpesvirus 1 vaccine;viral vaccine that is used to protect against psittacid herpesvirus 1 infection
independent continuant;lymphocytic choriomeningitis virus vaccine;a viral vaccine against infection of a lymphocytic choriomeningitis virus.
independent continuant;edwardsiella vaccine;a bacterial vaccine that is used to protect against edwardsiella bacterial infection
independent continuant;e. coli dna vaccine;e. coli dna vaccine is a dna vaccine that protects against an e. coli infection.
independent continuant;clostridium botulinum vaccine;a vaccine that protects against clostridium botulinum .
independent continuant;saccharomyces cerevisiae vaccine vector;a recombinant vaccine vector that uses saccharomyces cerevisiae as the vaccine vector
independent continuant;sodc from b. abortus strain 2308;a brucella abortus gene that has the name sodc and comes from strain 2308. 
independent continuant;recombinant vaccine vector e. coli vaccine;an e. coli vaccine that uses a recombinant vaccine vector to express an e. coli antigen(s)
independent continuant;polysaccharide subunit vaccine;a subunit vaccine that uses polysaccharide as protective antigen
independent continuant;human albumin cell culture residual in vaccine;a cell culture residual in vaccine that is human albumin.
independent continuant;advax-cpg55.2;advax-cpg55.2 is a combination adjuvant that includes an inulin-based polysaccharide (advax) and a cpg oligodeoxynucleotide cpg55.2.
independent continuant;rickettsial vaccine;a bacterial vaccine that protects against diseases caused by various species of rickettsia. typhus is any of several similar diseases caused by rickettsia bacteria. so rickettsial vaccine is also called typhus vaccine. 
independent continuant;human serum albumin vaccine additive;a protein vaccine stablizer that is specifically human serum albumin.
independent continuant;cov2 sam;a sars-cov-2 rna vaccine that has a lipid nanoparticle (lnp) platform and spike protein antigen
independent continuant;cov2-ogen1;a sars-cov-2 subunit vaccine that is orally administered and manufactured by syneos health
independent continuant;mva expressing hiv gag, pol and env proteins;a recombinant modified vaccinia ankara (mva) expressing hiv gag, pol, and env proteins. pmid: 16472543.
independent continuant;intragastric injection route;a intragastric route that has a vaccine injection site located in stomach.
independent continuant;mycobacterium bovis vaccine;a vaccine that protects against infection with mycobacterium bovis
independent continuant;av-covid-19;a sars-cov-2 vaccine consisting of autologous dendritic cells previously loaded ex vivo with spike protein.
independent continuant;chadox1-mers-s vaccine;a mers recombinant vector made of chimpanzee adenovirus oxford 1 vector expressing s protein from mers-cov 
independent continuant;herpes simplex virus vaccine vector;a herpesvirus vaccine vector that uses a herpes simplex virus strain
independent continuant;mumps virus vaccine;a viral vaccine that protects against infection with mumps virus.
independent continuant;protein cochleates vaccine adjuvant;a synthetic vaccine adjuvant synthesized from stable protein phospholipid-calcium precipitates.
independent continuant;polysorbate 20 vaccine stabilizer;a vaccine stabilizer that is a polysorbate 20. it encourages the suspension of one liquid in another and has mild toxicity.
independent continuant;non-small cell lung cancer vaccine;a cancer vaccine against non-small cell lung cancer (nsclc)
independent continuant;diphtheria-tetanus-whole cell pertussis-haemophilus b vaccine;a combination vaccine that protects against diphtheria, tetanus, pertussis, and haemophilus influenzae type b.
independent continuant;as-2 vaccine adjuvant;smithkline beecham adjuvant system 2 (as-2) is a combination vaccine adjuvant and is based on the combination of monophosphoryl lipid a(mpl), qs21 (a purified fraction of saponin extracted from quillarja saponaria), and a proprietary oil in water emulsion.
independent continuant;gerbu vaccine adjuvant;gerbu adjuvant is a combination vaccine adjuvant that is comprised of a mixture of gmdp, dda, and zinc l-proline salt complex (znpro8).
independent continuant;mr-vax ii;a live virus vaccine for immunization against measles and rubella.
independent continuant;rotashield vaccine;a rotavirus vaccine against severe diarrheal disease.
independent continuant;alhydrogel vaccine adjuvant;an aluminum hydroxide vaccine adjuvant that is a gel that is made by precipitation of aluminum hydroxide al(oh)3 under alkaline conditions.
independent continuant;sars ndv-bc/s vaccine;a sars-cov recombinant vector vaccine that is made from the newcastle disease virus from the mesogenic beaudette c strainexpressing sars-cov s protein.
independent continuant;leishmania major vaccine;a vaccine that protects against leishmania major.
independent continuant;pet11d dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pet11d. this plasmid is 5674 base pairs in length and contains an ampicillin resistance gene.
independent continuant;mva-sars-2-s;a sars-cov-2 recombinant vector vaccine that contains a modified vaccinia virus ankara (mva) vector expressing the sars-cov-2 spike protein (s)
independent continuant;canine adenovirus type 2 vaccine;viral vaccine that is used to protect against canine adenovirus type 2 (canine adenovirus 2) infection
independent continuant;t. cruzi dna vaccine encoding g2;a t. cruzi dna vaccine that uses a dna plasmid pgfp expressing t. cruzi g2 protein.
independent continuant;virus-like particle vaccine;a vaccine that uses virus-like particles (vlps), multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccines.
independent continuant;covivac;a sars-cov-2 recombinant newcastle disease virus vector vaccine expressing membrane-anchored pre-fusion-stabilized trimeric sars-cov-2 s protein
independent continuant;mvc-cov1901;a sars-cov-2 subunit vaccine that contains the spike (s) protein with cpg 1018 and aluminum content as adjuvant.
independent continuant;salmonella typhi vaccine;a salmonella vaccine against typhoid fever (or called typoid), caused by salmonella enterica enterica, serovar typhi. 
independent continuant;vaccinee;an organism that is vaccinated with a vaccine
independent continuant;lumpy skin disease virus vaccine vector;a poxvirus vaccine vector that uses an attenuated lumpy skin disease virus as the vector. 
independent continuant;virivac;a combined live virus vaccine used to prevent measles, mumps, and rubella.
independent continuant;proquad;a measles-mumps-rubella-vericella vaccine that is live and manufactured by merck & co, inc. 
independent continuant;mrna-1273.211;a multivalent sars-cov-2 mrna booster vaccine which combines mrna-1273, moderna s authorized vaccine against ancestral strains, and mrna-1273.351 in a single vaccine at the 50 g dose level and lower.
independent continuant;adenovirus vaccine vector;a viral vaccine vector that uses an adenovirus as the vector.
independent continuant;p. falciparum vaccine combination b;a malaria vaccine that comprises recombinant plasmodium falciparum (p. falciparum) blood-stage proteins msp1, msp2 and resa, formulated with the adjuvant montanide isa 720. pmid: 14604568.
independent continuant;porcine rotavirus vaccine;viral vaccine that is used to protect against porcine rotavirus infection
independent continuant;recov;a sars-cov-2 subunit vaccine by jiangsu rec-biotechnology co., ltd.
independent continuant;sars rma15- e vaccine;a sars recombinant vector vaccine that is made from recombinant ma15 virulent mouse-adapted sars-cov (ma15) background of e-deleted vaccine candidate (rma15- e)
independent continuant;rinderpest virus vaccine;a viral vaccine that protects against infection with rinderpest virus
independent continuant;staphylococcus aureus gene;a bacterial gene that is from staphylococcus aureus.
independent continuant;mers-cov pcdna3.1-s1 dna vaccine;a mers dna vaccine made of plasmid that encodes the first 725 amino acids of s from mers-cov
independent continuant;recombinant y. pestis v antigen vaccine;a y. pestis subunit vaccine that uses recombinant y. pestis v antigen. pmid: 7622205.
independent continuant;ad5-ncov;a sars-cov-2 vaccine made of self-coding rna encoding sars-cov-2 spike protein encapsulated within a lipid nanoparticle.
independent continuant;parainfluenza 3 virus vaccine;a viral vaccine that protects against infection with parainfluenza 3 virus.
independent continuant;gamma inulin vaccine adjuvant;gamma inulin is a carbohydrate adjuvant that is a highly specific activator of the alternative pathway of complement in vitro and in vivo, and is composed of linear (unbranched) b-d-(2-1) polyfructofuranosyl-a-d-glucose.
independent continuant;vaccine adjuvant;a vaccine component that is chemical substance added to vaccine and enhance and direct immune response to protective antigen. many of vaccine adjuvants cause a range of serious side-effects.
independent continuant;mrna-1273.529;a sars-cov-2 mrna booster vaccine by moderna that targets the omicron variant
independent continuant;hib-imune;active immunization against haemophilius influenzae type b in recommended routinely for children at 24 months of age and for children at 15 months of age enrolled in child care facilities.
independent continuant;theramide vaccine adjuvant;a synthetic vaccine adjuvant called theramide that is composed of n-acetylglucosaminyl-n-acetylinuramyl-l-ala-d-isoglu-l-ala-dipalmitoxy propylamide (dtp-dpp).
independent continuant;pcmn160 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmn160. this plasmid has a cmv promoter.
independent continuant;feline immunodeficiency virus vaccine;viral vaccine that is used to protect against feline immunodeficiency virus infection
independent continuant;montanide incomplete seppic adjuvant;a montanide vaccine adjuvant that is a mineral oil adjuvant.
independent continuant;aahi-sc2;a sars-cov-2 rna vaccine by immunitybio, inc.
independent continuant;vaccine emulsifier;a vaccine additive that stabilizes the vaccine emulsification manufacturing process and makes emulsion of the vaccine easier. 
independent continuant;cocktail vaccine containing subunit vaccine and inactivated whole organism vaccine;a cocktail vaccine that contains both subunit vaccine and inactivated whole organism vaccines.
independent continuant;feline infectious peritonitis virus gene;a viral gene that is from feline infectious peritonitis virus.
independent continuant;scb-2020s;a sars-cov-2 subunit vaccine by clover biopharmaceuticals aus pty ltd that contains the s protein from the b.1.351 variant.
independent continuant;vaccinia virus vector;an orthopoxvirus vaccine vector that uses vaccinia virus as the vector
independent continuant;tensoactive compound vaccine adjuvant;a vaccine adjuvant that includes tensioactive material. tensioactive materials, surfactants or active surface agents are chemical substances with a polar-non polar structure. these substances have a tendency to locate themselves at the surface creating an adsorbed monomolecular layer on the interface.
independent continuant;pedvaxhib;pedvaxhib is a highly purified capsular polysaccharide (polyribosylribitol phosphate or prp) of haemophilus influenzae type b (haemophilus b, ross strain) that is covalently bound to an outer membrane protein complex (ompc) of the b11 strain of neisseria meningitidis serogroup b.
independent continuant;kconvac;a sars-cov-2 inactivated virus vaccine by shenzhen kangtai biological products and beijing minhai biotechnology co.
independent continuant;spring summer encephalitis vaccine;a tick-borne encephalitis virus vaccine used to prevent subtype far eastern tick-borne encephalitis virus (formerly known as russian spring summer encephalitis virus).
independent continuant;measles-mumps-rubella-varicella vaccine;a measles-mumps-rubella vaccine that also protects against varicella.
independent continuant;autographa californica multicapsid nucleopolyhedrovirus vaccine vector;an adenovirus vaccine vector that contains a deletion of the gp64 gene. as a result of the deletion, this vector is unable to propagate infection from cell to cell, and this defect results from both a severe reduction in the production of budded virions and the absence of gp64 on virions. 
independent continuant;coccidioides vaccine;a vaccine that protects against coccidioides spp.
independent continuant;bordetella bronchiseptica gene;a bacterial gene that is from bordetella bronchiseptica.
independent continuant;alzheimer vaccine;a vaccine that prevents or treats alzheimer disease.
independent continuant;whole organism vaccine;a vaccine that uses whole organism as its component
independent continuant;burkholderia pseudomallei vaccine;a vaccine that protects against burkholderia pseudomallei.
independent continuant;ipol;ipol, poliovirus vaccine inactivated is a sterile suspension of three types of poliovirus: type 1 (mahoney), type 2 (mef-1), and type 3 (saukett). ipol vaccine is a highly purified, inactivated poliovirus vaccine with enhanced potency.
independent continuant;vaccine conjugate protein;the conjugate protein is a part of a conjugate vaccine and acts as a carrier protein that is covalently attached to a vaccine antigen with poor antigenicity (e.g., a polysaccharide). a conjugate protein is able to induce t-cell-dependent immune responses and stimulate the production of immune memory.
independent continuant;coxsackievirus vaccine vector;a viral vaccine vector that uses a coxsackievirus strain
independent continuant;moraxella bovis vaccine;a bacterial vaccine against moraxella bovis infection. moraxella bovis is a gram-negative, aerobic, oxidase-positive diplococcus that is implicated in infectious bovine keratoconjunctivitis, an eye disease of cattle, also colloquially known as pink eye.
independent continuant;puse- dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label puse-. this plasmid is a mammalian expression vector derived from pci-neo.
independent continuant;b. abortus hsa-l7/l12;b. abortus l7/l12 is a b. abortus subunit vaccine using l7/l12 that is formed by recombinant human serum albumin (has)-l7/l12 fusion protein.
independent continuant;diphtheria-tetanus-acellular pertussis-haemophilus b vaccine;a combination vaccine that protects against diphtheria, tetanus, pertussis, and haemophilus influenzae type b.
independent continuant;c. posadasii dna vaccine encoding pra protein;a coccidioides vaccine that contains c. posadasii dna vaccine encoding pra protein
independent continuant;'streptococcus gene';a bacterial gene that is from streptococcus.
independent continuant;covivac;a sars-cov-2 inactivated whole virus vaccine developed by the chumakov centre at the russian academy of sciences
independent continuant;avian polyomavirus vaccine;viral vaccine that is used to protect against avian polyomavirus infection
independent continuant;brucella abortus dna vaccine pcdna-sod;a brucella abortus vaccine that expresses cu/zn sod with dna plasmid pcdna. pmid: 15039330.
independent continuant;adimrsc-2f;adimrsc-2f is a candidate vaccine against covid-19 developed by adimmune corporation (adimmune). using the baculovirus-insect cells expression system, the recombinant receptor binding domain (rbd) of sars-cov-2 spike (s) protein is amplified and purified. adimrsc-2f is formulated in the different dosages of spike (s) protein without/with aluminum content as adjuvant.
independent continuant;chimpanzee adenovirus oxford2 vaccine vector;a chimpanzee adenovirus vaccine vector developed by oxford by deleting e1/e3 from chad68 with a modified e4 region.
independent continuant;wibp-corv;a sars-cov-2 inactivated whole virus vaccine that is developed by the wuhan institute of biological products.
independent continuant;matrix-m vaccine adjuvant;a vaccine adjuvant comprised of 40 nm nanoparticles composed of quillaja saponins, cholesterol and phospholipid.
independent continuant;gmdp vaccine adjuvant;a synthetic vaccine adjuvant containing gmdp, a higly effective primary adjuvant.
independent continuant;atherosclerosis vaccine;a vaccine that prevents or treats atherosclerosis disease.
independent continuant;v-01-351/v-01d bivalence vaccine;a sars-cov-2 protein subunit vaccine manufactured by livzon pharmaceutical group inc.
independent continuant;pvacc4 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pvacc4. this plasmid is a derivative of pvacc1 and contains a cmv promoter.
independent continuant;pbc12b1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pbc12b1. this plasmid is a eukaryotic expression vector.
independent continuant;unvaccinated organism;an organism that is unvaccinated with a vaccine
independent continuant;tick-borne encephalitis virus gene;a viral gene that is from tick-borne encephalitis virus.
independent continuant;vxa-cov2-1;a sars-cov-2 adenoviral vector-based oral vaccine by vaxart expressing a sars-cov-2 antigen and dsrna adjuvant
independent continuant;sys6006;a sars-cov-2 mrna vaccine by cspc zhongqi pharmaceutical technology co., ltd.
independent continuant;actinobacillus pleuropneumoniae gene;a bacterial gene from actinobacillus pleuropneumoniae.
independent continuant;pmasia-tgd dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pmasia-tgd. this plasmid is based off of pmasia and contains a cmv promoter and kanamycin resistance gene.
independent continuant;polygen vaccine adjuvant;a synthetic vaccine adjuvant with the tradename polygen.
independent continuant;pancreatic cancer vaccine;a cancer vaccine that is used against pancreatic canceer.
independent continuant;covid-19 inactivated vaccine by the scientific and technological research council of turkey;a sars-cov-2 inactivated virus vaccine by the scientific and technological research council of turkey adjuvanted by aluminum hydroxide and cpg odn
independent continuant;algammulin vaccine adjuvant;a suspension of 1-2 m ovoids of immune stimulant gamma inulin (g-in) in which alum is embedded as a carrier for protein or other anionic antigens.
independent continuant;liver cancer vaccine;a cancer vaccine that is used against liver canceer.
independent continuant;sugar vaccine stabilizer;a vaccine stabilizer that is specifically made by a sugar.
independent continuant;montanide isa 720 vaccine adjuvant;a montanide vaccine adjuvant that is formulated as water-in-oil emulsions and induces high antibody titers in several animal species. it is a vaccine adjuvant composed of metabolizable oil and a surfactant system designed to make a water-in-oil emulsion. it has been used since 1992 in more than 50 clinical trials related to therapeutic vaccines against various diseases such as cancer and malaria.
independent continuant;autoimmune disease vaccine;a vaccine that prevents or treats an autoimmune disease.
independent continuant;human herpesvirus 1 gene;a viral gene that is from human herpesvirus 1.
independent continuant;virus protein;a protein from a virus
independent continuant;infectious bronchitis virus vaccine;viral vaccine that is used to protect against infectious bronchitis virus (ibv) infection
independent continuant;mrt5500;a sars-cov-2 mrna vaccine that is manufactured by sanofi pasteur
independent continuant;chinese academy of medical sciences covid-19 vaccine;a sars-cov-2 inactivated whole virus vaccine that is developed by the chinese academy of medical sciences .
independent continuant;advax vaccine adjuvant;a polysaccharide adjuvant derived from delta inulin
independent continuant;francisella tularensis gene;a bacterial gene that is from francisella tularensis.
independent continuant;clostridium vaccine;a bacterial vaccine that protects against infection with clostridium spp.
independent continuant;covid-19 rndv vector vaccine by laboratorio avi-mex;a recombinant newcastle disease virus vectored vaccine for sars-cov-2 by laboratorio avi-mex
independent continuant;pcp15/60 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcp15/60.
independent continuant;chlamydia muridarum vaccine;a chlamydia vaccine that protects against chlamydia muridarum.
independent continuant;imiquimod vaccine adjuvant;a synthetic vaccine adjuvant contiaing imiquimod a imidazoquinoline.
independent continuant;adenovirus type 7;an oral vaccine against adenovirus serotype 7.
independent continuant;brain cancer vaccine;a cancer vaccine that is used against brain canceer.
independent continuant;adenovirus type 4;an oral vaccine against adenovirus serotype 4.
independent continuant;brucella abortus gene;a brucella gene that is from b. abortus.
independent continuant;vsv g-mers vaccine;a mers recombinant vector virus made from chimeric virus based on the vesicular stomatitis virus (vsv) in which the g gene was replaced by mers-cov s gene (vsv g-mers).
independent continuant;capripoxvirus vaccine vector;a poxvirus vaccine vector that uses an attenuated capripoxvirus strain as the vaccine vector
independent continuant;pires1neo dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pires1neo. this plasmid is 5257 base pairs in length and contains an ampicillin resistance gene.
independent continuant;nanoparticle vector;a vaccine component composed of a synthetic component that is solid and spherical structures ranging to around 100 nm in size and prepared from natural or synthetic polymers.
independent continuant;cigb-669;a sars-cov-2 protein subunit vaccine based on recombinant rbd subunits manufactured by the center for genetic engineering and biotechnology (cigb).
independent continuant;sctv01c;a sars-cov-2 subunit vaccine by sinocelltech ltd.
independent continuant;pcdna3.1(zeo)+ dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna3.1(zeo)+. this plasmid is 5015 base pairs in length and contains a zeocin selectable marker, a cmv promoter, and an ampicillin resistance gene.
independent continuant;sodb(ft);sodbft is a live vaccine strain mutant of francisella tularensis with reduced fe-superoxide dismutase gene expression. ref: pmid: 18692537.
independent continuant;synflorix;synflorix is indicated for active immunization of infants and children from 6 weeks up to 5 years of age against streptococcus pneumoniae serotypes 1, 4, 5, 6b, 7f, 9v, 14, 18c, 19f and 23f and invasive disease caused by these serotypes (including sepsis, meningitis, bacteraemic pneumonia, pleural empyema and bacteraemia). 
independent continuant;adenovirus vaccine;a viral vaccine that protects against infection of an adenovirus.
independent continuant;menactra;menactra, meningococcal (groups a, c, y and w-135) polysaccharide diphtheria toxoid conjugate vaccine, is indicated for active immunization to prevent invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, y and w-135.
independent continuant;treponema pallidum vaccine;a bacterial vaccine against treponema pallidum infection
independent continuant;acwy vax;a licensed n. meningitidis vaccine that includes meningococcal polysaccharides from groups a, c, y and w-135 combined, and is manufactured by gsk.
independent continuant;vb10.2210;a sars-cov-2 t-cell-based dna vaccine developed by vaccibody as
independent continuant;formalin-killed vaccine;an inactivation vaccine that is prepared by formalin inactivation.
independent continuant;leptospira spp. vaccine;bacterial vaccine that is used to protect against leptospira spp. infection
independent continuant;recombinant sars spike polypeptide vaccine;a sars dna vaccine that is made from intraperitoneal recombinant spike polypeptide generated by amplififying gene encoding amino acids residues 14-667 of s protein that was cloned bamhi and kpni sites of vector pqe-31 that was generated by escherichia coli
independent continuant;coxiella burnetii vaccine;a bacterial vaccine against infection with coxiella burnetii which causes q fever
independent continuant;mycobacterium marinum vaccine;a vaccine that protects against mycobacterium marinum.
independent continuant;chimpanzee adenovirus vaccine vector;an adenovirus vaccine vector that uses a chimpanzee adenovirus strain
independent continuant;vrp expressing vp40;an ebola virus vaccine that is composed of vee replicon particle (vrp) encoding ebola virus vp40 protein.
independent continuant;streptococcus equi gene;a bacterial gene that is from streptococcus.
independent continuant;canine parvovirus vaccine;a vaccine that protects against canine parvovirus.
independent continuant;mycobacterium avium vaccine;a vaccine that protects against mycobacterium avium.
independent continuant;tdap/ipv vaccine foreign to usa;a vaccine against tetanus, diphtheria, pertussis, and inactivated poliovirus manufactured outside of the u.s.
independent continuant;diphtheria-tetanus-pertussis-poliovirus-hepatitis b vaccine foreign to usa;a diphtheria-tetanus-pertussis-poliovirus-hepatitis b vaccine manufactured outside of the u.s
independent continuant;prime-boost vaccine with dna vaccine priming;a vaccine that contains one dna vaccine for priming and at least one other vaccine for boosting. 
independent continuant;immunoliposomes containing antibodies to costimulatory molecules;immunoliposomes containing antibodies to costimulatory molecules is a liposome-based vaccine adjuvant which is prepared from dehydration-rehydration vesicles (drvs).
independent continuant;sii b.1.351;a sars-cov-2 monovalent protein subunit vaccine by novavax immunizing against the b.1.351 (beta) variant and containing the matrix-m1 adjuvant
independent continuant;human adenovirus vaccine vector;an adenovirus vaccine vector that uses a human adenovirus as the vector strain.
independent continuant;acm-001;a sars-cov-2 protein subunit vaccine manufactured by acm biolabs.
independent continuant;salmonella paratyphi vaccine;a salmonella vaccine against infection with s. paratyphi, which causes paratyphoid fevers. paratyphoid fevers are a group of enteric illnesses caused by serotypic strains of the salmonella genus of bacteria, s. paratyphi.
independent continuant;lvrna009;a sars-cov-2 mrna vaccine by aim vaccine co., ltd.
independent continuant;mvvac2-mers-n vaccine;a mers recombinant vector vaccine made of live-attenuated measles virus (mv) vaccine encoding the mers-cov nucleocapsid protein (mers-n).
independent continuant;caprine herpesvirus type 1 vaccine;a viral vaccine that protects against infection with caprine herpesvirus type 1 virus
independent continuant;human betaherpesvirus 5 vaccine;a viral vaccine that protects against infection with human herpesvirus 5.
independent continuant;sputnik v;a sars-cov-2 recombinant viral vector vaccine composed of ad26 and ad5 vectors expressing s protein that lyophilised.
independent continuant;arct-165;a sars-cov-2 rna vaccine by arcturus therapeutics, inc.
independent continuant;e. coli heat-labile toxin vaccine adjuvant;a microbial derivative vaccine adjuvant containing e. coli heat-labile toxin.
independent continuant;vaccine organism;an organism that is used as part of a vaccine
independent continuant;p1012 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label p1012.
independent continuant;hib polysaccharide foreign to usa;a haemophilis influenzae type b capsular polysaccharide vaccine manufactured outside of the u.s.
independent continuant;rubulavirus vaccine;a vaccine that is used against an infection by a pathogen under rubulavirus.
independent continuant;flagellin vaccine adjuvant;a microbial derivative vaccine adjuvant composed of flagellin from gram-negative bacteria.
independent continuant;aeromonas hydrophila vaccine;an aeromonas vaccine that protects against aeromonas hydrophila.
independent continuant;pmv10.1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pmv10.1. this plasmid contains a cmv promoter and a kanamycin resistance gene.
independent continuant;soberana 02;a sars-cov-2 subunit vaccine developed by finlay vaccine institute (ifv)
independent continuant;feline panleukopenia virus vaccine;viral vaccine that is used to protect against feline panleukopenia virus infection
independent continuant;cancer vaccine;a vaccine that prevents or treats cancer. it is produced using the patient's own whole tumor cells as the source of antigens, or using tumor-specific antigens, often recombinantly produced.
independent continuant;live attenuated brucella suis vaccine;live attenuated brucella vaccine is a live attenuated vaccine that protects against a brucella melitensis infection.
independent continuant;clostridium perfringens vaccine;bacterial vaccine that is used to protect against clostridium perfringens infection
independent continuant;schistosoma vaccine;a protozoan vaccine against schistosoma infection
independent continuant;'salmonella typhimurium gene;a bacterial gene that is from salmonella typhimurium.
independent continuant;ad35.cs.01 malaria vaccine;a p. falciparum malaria vaccine that is formed by tull length cs-expressing replication-deficient recombinant human adenovirus 35.
independent continuant;profertility vaccine;a vaccine that is used to improve conception.
independent continuant;abdala;a sars-cov-2 protein subunit vaccine based on recombinant rbd subunits manufactured by the center for genetic engineering and biotechnology (cigb).
independent continuant;quatro virelon;active immunization against tetanus, diphtheria, pertussis, and poliomyelitis for individuals between 3 months and 6 years of age.
independent continuant;p. falciparum rts,s/as01;a malaria vaccine that consists of hepatitis b surface antigen virus-like particles, incorporating a portion of the plasmodium falciparum-derived circumsporozoite protein and a liposome-based adjuvant.
independent continuant;inactivated avian influenza vaccine;an avian influenza vaccine that uses inactivated viral organism
independent continuant;usa licensed vaccine;a vaccine licensed in the usa
independent continuant;yersinia ruckeri vaccine;a bacterial vaccine against yersinia ruckeri infection
independent continuant;mpl-se vaccine adjuvant;a microbial derivative vaccine adjuvant containing mpl and squalene.
independent continuant;pgacag dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pgacag. the promoter is cag and the antibiotics resistance gene is kanamycin.
independent continuant;mineral salt vaccine adjuvant;a vaccine adjuvant that is formed as a mineral salt.
independent continuant;bcg vaccine vector;a bacterial vaccine vector that uses tb vaccine bcg as the vector.
independent continuant;leishmania amazonensis vaccine;a vaccine that protects against leishmania amazonensis.
independent continuant;live attenuated newcastle disease virus vaccine;a viral vaccine that protects aganist newcastle disease virus infection.
independent continuant;live attenuated marek's disease virus vaccine;a vaccine that protects against marek's. disease virus.
independent continuant;mycobacterium smegmatis vaccine vector;a bacterial vaccine vector that uses an attenuated mycobacterium smegmatis strain
independent continuant;b16 vaccine adjuvanted by loxoribine;a cancer vaccine that protects mice against tumor growth following challenge with live b16 cells.
independent continuant;t. cruzi par1 protein vaccine;a t. cruzi subunit vaccine that uses t. cruzi par1 protein as protective antigen.
independent continuant;salmonella-tpa-s sars dna vaccine;a sars dna vaccine made from ctla4hingesars800 dna with sars-cov s protein
independent continuant;lymerix;lymerix [lyme disease vaccine (recombinant ospa)] is a noninfectious recombinant vaccine developed and manufactured by smithkline beecham biologicals. the vaccine contains lipoprotein ospa, an outer surface protein of borrelia burgdorferi sensu stricto zs7, as expressed by escherichia coli. lipoprotein ospa is a single polypeptide chain of 257 amino acids with lipids covalently bonded to the n terminus.
independent continuant;cholera toxin vaccine adjuvant;a microbial derivative vaccine adjuvant consisting of cholera toxin (ct) from vibrio cholerae.
independent continuant;dna vaccine;dna vaccine is a vaccine that is composed of a plasmid vaccine vector (a circular double stranded dna molecule) containing genes encoding one or more proteins of a pathogen.
independent continuant;vr2210 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vr2210. this plasmid contains a cmv promoter and kanamycin resistance gene. it was created through ligation of fragments of digested plasmid vr1012, htpa, and b. burgdorferi b31 ospa.
independent continuant;prostate cancer vaccine;a cancer vaccine that is used against prostate cancer.
independent continuant;rmv-s + rmv-n vaccine;a sars dna vaccine made up of arecombinat vector vaccine made from recombinant measles virus expressing s protein and recombinant measles virus expressing n protein.
independent continuant;vrp-mers-n vaccine;a mers recombinant vector made from venezuelan equine encephalitis replicons bearing epitopes of n protein from mers. crosslisted as sars vaccine (violinid:5754). efficacy higher intranasally than subcutaneously.
independent continuant;corynebacterium vaccine;a vaccine that is used against an infection by a pathogen under corynebacterium.
independent continuant;pusk dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pusk.
independent continuant;canine adenovirus type 1 vaccine;viral vaccine that is used to protect against canine adenovirus type 1 (canine adenovirus 1) infection
independent continuant;chikungunya virus vaccine;a viral vaccine that protects against infection with chikungunya virus
independent continuant;loxoribine vaccine adjuvant;a synthetic vaccine adjuvant loxoribine is a guanosine analog derivatized at position n7 and c8, and activates tlr-7.
independent continuant;inactivated vaccine;a whole organism vaccine that uses an inativated pathogen organism as its component.
independent continuant;cpg dna vaccine adjuvant;a microbial derivative vaccine adjuvant compsed of cpg dna.
independent continuant;aav vaccine vector;a viral vaccine vector that uses an aav virus as the vector.
independent continuant;sars n + sars m dna vaccine;'a sars dna combination vaccine that is made from recombinant plasmids containing membrane protein (m) and nucleocapsid protein (n) sequences constructed then expressed and purified from e. coli bacteria 
independent continuant;herpesvirus vaccine vector;a viral vaccine vector that uses a herpesvirus as the vector.
independent continuant;equid herpesvirus 1 vaccine;viral vaccine that is used to protect against equid herpesvirus 1 infection
independent continuant;dtp-acthib;a vaccine used to prevent diphtheria, tetanus, pertussis, and haemophilus type b infections.
independent continuant;leishmania infantum gene;a protozoan gene that is from leishmania infantum.
independent continuant;bordetella avium vaccine;a bordetella bacterial vaccine against infection of b. avium
independent continuant;aeromonas salmonicida gene;a bacterial gene that is from aeromonas salmonicida.
independent continuant;fungal vaccine vector;a recombinant vaccine vector that uses a fungus as the vaccine vector
independent continuant;canarypox virus vaccine;viral vaccine that is used to protect against canarypox virus infection
independent continuant;iscom vaccine adjuvant;a particulate antigen delivery system, iscom is a vaccine adjuvant that consists of an assembly of antigens in multimeric form and presents an antigen to induce specific immunologic responses. the assembly is attached to a matrix with a built-in adjuvant, saponin. iscoms induce strong serum antibody responses, and are used as highly immunogenic forms of subunit vaccines. mesh term: d20.215.894.860.449.
independent continuant;adjuvax vaccine adjuvant;glucan carbohydrate microcapsules with a (1-3)/ (1-6) - linked glucan structure to allow targeting of antigens to macrophages or neutrophils through interactions with the -glucan receptor found uniquely on the surface of these cell types. adjuvax- ligand complexes are formed by physically entrapping or crosslinking the ligand within the -glucan.
independent continuant;streptococcus pyogenes vaccine;a streptococcus vaccine against streptococcus pyogenes infection.
independent continuant;duck enteritis virus vaccine;viral vaccine that is used to protect against duck enteritis virus (anatid herpesvirus 1) infection
independent continuant;gls-5310;a sars-cov-2 plasmid dna vaccine developed by geneone life science.
independent continuant;vaccine strain;a vaccine organism that is a specific strain
independent continuant;covigen;a sars-cov-2 dna vaccine manufactured by university of sydney, bionet co., and technovalia
independent continuant;lymphoma vaccine;a cancer vaccine that is used against lymphoma.
independent continuant;pox vaccine;a viral vaccine against a disease caused by a virus belong to poxviridae. 
independent continuant;mink enteritis virus vaccine;viral vaccine that is used to protect against mink enteritis virus infection
independent continuant;vaccine residual;a vaccine component that remains from the vaccine manufacturing process.
independent continuant;vee virus gene;a viral gene that is from vee virus.
independent continuant;lnp-ncovsarna;a sars-cov-2 rna vaccine made of self-coding rna encoding sars-cov-2 spike protein encapsulated within a lipid nanoparticle.
independent continuant;vaccine candidate;vaccine candidate is a processed material that is designed to prevent or ameliorate a disorder in a target organism by modulating adaptive immune responses in that organism by administrating the vaccine.
independent continuant;recombinant bcg vaccine;a tb vaccine that uses bcg as vaccine vector.
independent continuant;human rabies vaccine;a rabies virus vaccine against rabies in human
independent continuant;bovine herpesvirus 1 gene;a viral gene that is from bovine herpesvirus 1.
independent continuant;lactose vaccine stabilizer;a vaccine stabilizer that is specifically made by a lactose.
independent continuant;2012-2013 seasonal trivalent inactivated influenza vaccine (a/california/7/2009 (h1n1), a/victoria/361/2011 (h3n2), and b/wisconsin/1/2010);2012-2013 trivalent seasonal inactivated influenza vaccine 2012-2013 influenza a virus (a/california/7/2009 (h1n1)), influenza a virus (a/victoria/361/2011 (h3n2)), and influenza b virus (b/wisconsin/1/2010)
independent continuant;infectious bursal disease virus vaccine;viral vaccine that is used to protect against infectious bursal disease virus (ibdv) infection
independent continuant;kbp-covid-19;a sars-cov-2 subunit vaccine that is made of a protein subunit made of the rbd domain of the s protein.
independent continuant;porphyromonas gulae vaccine;a bacterial vaccine against porphyromonas gulae infection
independent continuant;campylobacter jejuni vaccine;a campylobacter vaccine that protects against campylobacter jejuni.
independent continuant;calcium phosphate gel vaccine adjuvant;a calcium phosphate vaccine adjuvant that is a gel prepared by precipitating soluable calcium and phosphate salts.
independent continuant;alvac vaccine vector;a canarypox vaccine vector that uses an attenuated canarypox virus strain alvac. the alvac vector is a canarypox virus clone obtained after four rounds of plaque purification of a strain from a vaccine for canaries. 
independent continuant;aluminum hydroxide vaccine adjuvant;an aluminum vaccine adjuvant that contains aluminum hydroxide.
independent continuant;crimean-congo haemorrhagic fever vaccine;a viral vaccine that protects against infection with cchf virus
independent continuant;mers-cov s vaccine adjuvanted with cpg and alum;a mers subunit vaccine that has a combined adjuvant of aluminum hydroxide and cpg oligodeoxynucleotides.
independent continuant;mers england1 s dna vaccine;a mers dna vaccine made of the vrc8400 plasmid that encodes the full-length, membrane anchore mers spike protein
independent continuant;part of pathogen organism in vaccine;'part of organism in vaccine' is a pathogen component in vaccine that contains only a part of the pathogen organism instead of the whole organism.
independent continuant;rov-asp-1 vaccine adjuvant;rov-asp-1 stands for recombinant onchocerca volvulus activation-associated secreted protein-1. it is a potent adjuvant for antibody and cellular responses to protein, polypeptide and small peptide antigens. onchocerca volvulus, the helminth parasite that causes onchocerciasis, known more commonly as river blindness.
independent continuant;infectious salmon anemia virus vaccine;viral vaccine that is used to protect against infectious salmon anemia virus infection
independent continuant;mers gls-5300 vaccine;a mers dna vaccine that is made of the plasmid pgx9109 expressing mers s protein.
independent continuant;canada licensed human vaccine;a licensed human vaccine that is licensed in canada
independent continuant;chad63-kh vaccine;replication defective simian adenoviral vector expressing kh, a self-cleaving polyprotein comprising l. donovani kmp-11 and haspb
independent continuant;synchotrope ta2m dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label synchotrope ta2m. this plasmid is 3683 base pairs in length and has two copies of the murine cpg immune stimulatory sequence aacgtt inserted.
independent continuant;ptpa-pa63-lamp1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label ptpa-pa63-lamp1.
independent continuant;eastern equine encephalitis virus vaccine;viral vaccine that is used to protect against eastern equine encephalitis virus infection
independent continuant;rabipur vaccine;a vaccine used to help prevent rabies infection in people who either have been, or are at risk of being bitten, licked or scratched by an animal infected with rabies virus.
independent continuant;brucella vaccine;a vaccine that protects against brucella that causes brucellosis in animals and humans.
independent continuant;prophylactic vaccine;a vaccine that is used for prevention against a disease.
independent continuant;covlp;a recombinant coronavirus-like particle sars-cov-2 vaccine developed by medicago
independent continuant;stearyl tyrosine vaccine adjuvant;a synthetic vaccine adjuvant stearyl tyrosine is considered an "organic equivelant" of aluminum hydroxide.
independent continuant;eucorvac-19;a sars-cov-2 protein subunit vaccine by eubiologics co., ltd.
independent continuant;synthetic vaccine adjuvant;a vaccine adjuvant that contains synthetic material.
independent continuant;animal rabies vaccine;a rabies virus vaccine against rabies in animal
independent continuant;soberana plus;a sars-cov-2 protein subunit vaccine manufactured by instituto finlay de vacunas. it is used as a booster dose for the soberana 02 covid-19 vaccine
independent continuant;brucella abortus vaccine strain 19;a live attenuated brucella abortus vaccine that is licensed and used in many countries.
independent continuant;adcovid;a sars-cov-2 single dose intranasal vaccine manufactured by altimmune in collaboration with the university of alabama-birmingham. this vaccine was discontinued after a phase 1 trial.
independent continuant;sars ctla4-s dna vaccine;a sars dna vaccine that is made from ctla4hingesars800 dna with sars-cov s protein
independent continuant;west nile virus vaccine;a viral vaccine that protects against west nile virus infection.
independent continuant;psectag2b dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psectag2b. this plasmid is 5163 base pairs in length and contains a cmv promoter and ampicillin resistance gene.
independent continuant;hpv-16 l1 vlp;a human paillomavirus vaccine that has the vaccine antigen ingredient of monovalent non-infectious, l1 recombinant hpv-like particles (vlp).
independent continuant;human metapneumovirus gene;a viral gene that is from human metapneumovirus.
independent continuant;respiratory syncytial virus vaccine;a viral vaccine that prevents infection with respiratory syncytial virus.
independent continuant;montanide isa51 vaccine adjuvant;a montanide vaccine adjuvant that is a vaccine adjuvant composed of a light mineral oil and a surfactant system designed to make a water-in-oil emulsion.
independent continuant;pcmv/myc/er dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmv/myc/er. this plasmid is 5066 base pairs in length and contains a cmv promoter and ampicillin resistance gene.
independent continuant;grt-r912;a sars-cov-2 rna vaccine by gritstone bio, inc.
independent continuant;listeria monocytogenes vaccine vector;a bacterial vaccine vector that uses l. moncytogenes as the vector.
independent continuant;(h115d)vhl35 peptide cancer vaccine;a peptide vaccine derived from the von hippel-lindau (vhl) tumor suppressor protein, a general transcription factor. in (h115d)vhl35 peptide, histidine is substituted for an aspartic acid in position 115. it might be used to elicit or boost cellular immunity to cancers that expressing the von hippel-lindau mutation.
independent continuant;pci dna vaccine plasmid;a dna vaccine plasmid that uses the plasmid labeled pci.
independent continuant;trichinella spiralis vaccine;a protozoan vaccine against trichinella spiralis infection
independent continuant;fowlpox virus vaccine;viral vaccine that is used to protect against fowlpox virus infection
independent continuant;covi vax;a sars-cov-2 inactivated vaccine developed by the national research centre of egypt
independent continuant;zycov-d;a sars-cov-2 plasmid dna vaccine that encodes the envelope protein.
independent continuant;tick-borne encephalitis virus (tbev) vaccine;a vaccine that protects against tick-borne encephalitis virus (tbev).
independent continuant;tomatine vaccine adjuvant;a steroid alkaloid that is tomatidine in which the hydroxy group at position 3 is linked to lycotetraose, a tetrasaccharide composed of two units of d-glucose, one unit of d-xylose, and one unit of d-galactose.
independent continuant;pvr1020 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pvr1020. this plasmid contains a cmv promoter and kanamycin resistance gene.
independent continuant;poly(i:c) vaccine adjuvant;a synthetic vaccine adjuvant containing poly(i:c), a synthetic double stranded analog of rna.
independent continuant;equine arteritis virus vaccine;viral vaccine that is used to protect against equine arteritis virus infection
independent continuant;usa licensed cattle vaccine;a cattle vaccine with license that is used in usa.
independent continuant;human vaccinee;a vaccinee that is a human being
independent continuant;bordetella vaccine;a bacterial vaccine against infection of bordetella bacterial infection
independent continuant;genhevac b;this absorbed recombinant hepatitis b vaccine is indicated for active immunization against hepatitis b virus infection caused by all known subtypes in subjects of any age considered at risk of exposure to the virus.
independent continuant;morbillivirus vaccine;a vaccine that is used against an infection by a pathogen under morbillivirus.
independent continuant;ty particles vaccine adjuvant;a microbial derivative vaccine adjuvant made of virus like particles (vlps) containing the yeast retrotransposon ty which has the amino acids 1-381 of the pi protein encoded.
independent continuant;uropathogenic e. coli vaccine;an e. coli vaccine against uropathogenic e. coli infections
independent continuant;equity;equity oestrus control vaccine for horses is prepared from an analogue of gonadotropin releasing factor (gnrf) linked to a carrier protein. it has an adjuvant that enhances the level and duration of the immune response to gnrf with minimal injection site reactivity. it is used as an aid in the control of oestrus and oestrus-related behaviour in fillies and mares not intended for breeding.
independent continuant;chad-tricov/mac;a sars-cov-2 replication deficient chimpanzee adenovirus 68 vector vaccine expressing the spike, nucleocapsid and rna polymerase proteins.
independent continuant;pharyngeal mucosal route;pharyngeal mucosal route is an oral route of administration.
independent continuant;pseudorabies virus strain bartha vaccine vector;a herpesevirus vaccine vector that uses an established live-virus vaccine against aujeszky's disease of swine, pseudorabies virus (prv) strain bartha (prv-ba), to serve as vector.
independent continuant;rc529 vaccine adjuvant;a synthetic vaccine adjuvant named rc529 that is a lipid a mimetic.
independent continuant;mers rntd vaccine;a mers subunit vaccine made of a neutralizing monoclonal antibodiesagainst mers-cov which bind to the n-terminal domain (ntd) of the mers-cov s1 subunit that was expressed by baculovirus-insect cell sf9-derived recombinant mers-cov.
independent continuant;ad26.cov2.s;a sars-cov-2 recombinant viral vector vaccine composed of ad26 vector expressing s protein.
independent continuant;amino acid vaccine stabilizer;a vaccine stabilizer that is generated based on amino acids. 
independent continuant;bacterial vaccine vector;a vaccine vector that uses a live bacterium as the vector 
independent continuant;arcov;a sars-cov-2 mrna vaccine made of lipid nanoparticle-encapsulated mrna (mrna-lnp) encoding the receptor binding domain (rbd) of sars-cov-2 manufactured by academy of military science (ams), walvax biotechnology, and suzhou abogen biosciences.
independent continuant;extraintestinal pathogenic e. coli vaccine;an e. coli vaccine against extraintestinal pathogenic e. coli infections
independent continuant;fish vaccine;vaccine that used for immunizing fishes
independent continuant;ditanrix;a diphthpheria-tetanus absorbed vaccine for children 7 years of age and adults.
independent continuant;pwrg dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pwrg. this plasmid is a eukaryotic expression plasmid that contains the immediate early promoter and intron a of human cytomegalovirus.
independent continuant;licensed cattle vaccine;a vaccine with license that is used for cattle.
independent continuant;alphavirus vaccine vector;a viral vaccine vector that uses an alphavirus as the vector.
independent continuant;pasteurella multocida gene;a bacterial gene that is from pasteurella multocida.
independent continuant;ltk63 vaccine mutant;a microbial derivative vaccine adjuvant that is a mutant form of lt containing a ser-lys substitution in position 63 which has been shown to be totally devoid of toxicity stable to protease treatment and able to act as mucosal adjuvant.
independent continuant;particulate antigen delivery system;a vaccine adjuvant that serves as a particulate antigen delivery system.
independent continuant;sars ads-mva vaccine;a sars recombinant vector vaccine that is made from a recombinant live-attenuated modified vaccinia virus ankara (mva) that had a full-length sars-cov envelope spike (s) glycoprotein gene introduced into the deletion iii region of the mva genome.
independent continuant;measles-rubella vaccine;a measles virus vaccine that is also used against rubella virus infection.
independent continuant;pcaggsp7 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcaggsp7. this plasmid has a polylinker containing kpni, xhoi, clai, ecorv, smai, not1 and sac1 sites inserted into the ecori site of pcaggs.
independent continuant;mycobacterium tuberculosis rd1/pancd mutant vaccine;rd1 and pancd mutants in mycobacterium tuberculosis were attenuated and provided protection in cd4-deficient mice against an aerosol challenge with virulent m. tuberculosis
independent continuant;edwardsiella tarda vaccine;an edwardsiella bacterial vaccine that protects against edwardsiella tarda.
independent continuant;vrc-9123 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vrc-9123.
independent continuant;moderna covid-19 vaccine;a sars-cov2 rna vaccine made of lipid nanoparticle with mrna which encodes the s-2p antigen, made of the sars-cov-2 glycoprotein with a transmembrane anchor and intact s1-s2 cleavage site.
independent continuant;mers england1 s dna + england1 s protein subunit vaccine;a mers combination vaccine made of made of the vrc8400 plasmid that encodes the full-length, membrane anchore mers spike protein and a dna vaccine that is a plasmid that encoded s1 subunit
independent continuant;vaccine containing dna vaccine for priming and subunit vaccine for boosting;a prime-boost vaccine with dna vaccine priming that contains a subunit vaccine for boosting
independent continuant;bordetella pertussis component vaccine adjuvant;a microbial derivitive vaccine adjuvant that contains components from killed bordetella pertussis. the killed b. pertussis has a strong adjuvant effect on the diphtheria and tetanus toxoids in the dpt vaccines.
independent continuant;adimrsc-2f;a sars-cov-2 protein subunit vaccine developed by adimmune corporation.
independent continuant;vaccine additive;a vaccine component that is added to the immunogen by the vaccine manufacturer for a specific purpose. additives include adjuvants, preservatives and stablizers, as well as materials that are added to affect ph and isotonicity.
independent continuant;nkcmvintpolyli dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label nkcmvintpolyli. this plasmid contains a cmv promoter.
independent continuant;brucella abortus vaccine rb51;brucella abortus vaccine rb51 is a brucella abortus vaccine that is licensed in the usa since 1992.
independent continuant;vibrio cholerae vaccine vector;a bacterial vaccine vector that uses an attenuated vibrio cholerae strain
independent continuant;diphtheria-tetanus-pertussis-poliovirus-hepatitis b vaccine;a vaccine used to prevent infections of diphtheria, tetanus (lockjaw), pertussis (whooping cough), hepatitis b, and poliovirus.
independent continuant;corbevax;a sars-cov-2 vaccine that includes a protein antigen, sars-cov-2 spike rbd, adsorbed to the adjuvant alhydrogel (alum), in combination with another approved adjuvant, cpg 1018
independent continuant;duck enteritis virus vector;a viral vaccine vector that uses a duck enteritis virus strain
independent continuant;eg-covid;a sars-cov-2 rna vaccine by eyegene inc.
independent continuant;neisseria meningitidis gene;a bacterial gene that is from neisseria meningitidis.
independent continuant;fusion conjugate protein vaccine;a conjugate vaccine that conjugate more than one open reading frames of protective antigens or conjugate a protective antigen to a carrier protein.
independent continuant;hepatitis b virus gene;a viral gene that is from hepatitis b virus.
independent continuant;staphylococcal vaccine;a bacterial vaccine that protects against infection with staphylococcus.
independent continuant;plxshd dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label plxshd. this plasmid has a murine leukemia virus enhancer-promoter ltr.
independent continuant;vla2001;a sars-cov-2 inactivated, vero-cell based vaccine adjuvanted with aluminum and cpg 1018. it uses the manufacturing platform of valneva s commercial japanese encephalitis (je) vaccine
independent continuant;ptx-covid19-b;a sars-cov-2 mrna vaccine by providence therapeutics
independent continuant;vibrio anguillarum vaccine;a bacterial vaccine against v. anguillarum infection
independent continuant;meningococcal conjugate vaccine;meningococcal conjugate vaccine, which contains four of the most common types of meningococcal bacteria (serogroups a, c, w, and y), is used to prevent infection caused by meningococcal bacteria.
independent continuant;crt-n sars vaccine;a sars dna vaccine made from encoding calrectulin linked to a sars-cov n protein
independent continuant;phw2000 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label phw2000. this plasmid is derived from phw12 and contains part of the human pol i promoter and murine terminator sequences, a cmv promoter, and the polyadenylation signal of the gene encoding bovine growth hormone.
independent continuant;il-12 vacince adjuvant;a cytokine vaccine adjuvant that includes il-12.
independent continuant;salmonella enteritidis vaccine;a bacterial vaccine that protects against infections by salmonella enterica subsp. enterica serovar enteritidis.
independent continuant;b. abortus bls-l7/l12;b. abortus bls-l7/l12 is a b. abortus subunit vaccine using l7/l12 that is made as a recombinant bls-l7/l12 fusion protein vaccine.
independent continuant;live attenuated brucella vaccine;live attenuated brucella vaccine is a live attenuated vaccine that protects against a brucella infection.
independent continuant;nanoemulsion vaccine adjuvant;nanoemulsion vaccine adjuvant is an emulsion vaccine adjuvant and is made from non-toxic lipid droplets a few hundred nanometers in diameter and made from surfactants approved for human consumption and common food substances that are 'generally recognized as safe' (gras) by the fda.
independent continuant;salmonella gallinarum gene;a bacterial gene that is from salmonella gallinarum.
independent continuant;sars m protein dna vaccine;'a sars dna vaccine that is made from recombinant plasmid containing membrane protein (m) sequence constructed then expressed and purified from e. coli bacteria 
independent continuant;poliovirus vaccine;a viral vaccine that protects against infection with poliovirus.
independent continuant;porcine respiratory and reproductive syndrome virus vaccine;viral vaccine that is used to protect against porcine respiratory and reproductive syndrome virus (porcine reproductive and respiratory syndrome virus) infection
independent continuant;malaria vaccine;plasmodium vaccine is a vaccine that prevents against plasmodium species causing malaria. it is made from antigens arising from any of the four strains of plasmodium which cause malaria in humans, or from p. berghei which causes malaria in rodents.
independent continuant;mycoplasma gallisepticum vaccine;a bacterial vaccine against mycoplasma gallisepticum infection
independent continuant;pfspz vaccine;a plasmodium falciparum vaccine that is composed of aseptic, purified, live (metabolically active), radiation-attenuated, cryopreserved plasmodium falciparum sporozite.
independent continuant;glycerol vaccine adjuvant;a naturally occurring trivalent alcohol
independent continuant;canine parainfluenza virus vaccine;viral vaccine that is used to protect against canine parainfluenza virus infection
independent continuant;nyvac vaccine vector;a vaccinia vaccine vector that uses the highly attenuated nyvac as vector
independent continuant;e. coli subunit vaccine;an e. coli vaccine that uses subunit antigen type.
independent continuant;covid-19 vaccine;a coronavirus vaccine against the infection of sars-cov-2 (cause of covid-19)
independent continuant;vaccine allergen;vaccine allergen is a material entity that is capable of stimulating a type-i hypersensitivity reaction in atopic individuals who has been vaccinated with a vaccine.
independent continuant;brucella suis vaccine;a brucella vaccine against infection wtih b. suis
independent continuant;infanrix quinta;a combination vaccine against diphtheria, tetanus, pertussis, poliomyelitis, and haemophilus influenzae type b (hib).
independent continuant;inactivated whole (formalin and uv radiation) sars-cov vaccine;a sars inactivated vaccine made from inactivated whole virus by formalin and ultraviolet radiation, hence double inactivated (di) vaccine
independent continuant;hdt-301;a sars-cov-2 lipid-inorganic nanoparticle (lion ) formulated replicating mrna vaccine that encodes for a full-length spike (s) protein of the sars-cov-2 virus
independent continuant;vr1055 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vr1055. this plasmid is derived from puc19 and contains a cmv promoter, kanamycin resistance gene, a cloning polylinker, and a transcriptional terminator region derived from the rabbit beta-globin gene.
independent continuant;plasmodium yoelii gene;a plasmodium gene that is from plasmodium yoelii.
independent continuant;sars vaccine;a vaccine that protects against sars-cov.
independent continuant;anthrax spore vaccine;anthrax spore vaccine is a b. anthracis vaccine that is prepared with a relatively nonpathogenic, noncapsulated variant strain of b. anthracis, originally developed at the onderstepoort laboratory, pretoria, south africa. further work was conducted in england, india and in many other countries. vaccine strain is sterne 34f2. the vaccine is a suspension of viable bacillus anthracis spores in saponin.
independent continuant;auxo-gtu dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label auxo-gtu.
independent continuant;um-3003 vaccine adjuvant;um-3003 is a small molecule tlr7/8 agonist that can stimulate th1-biased immune profile.
independent continuant;sars n protein dna vaccine;'a sars dna vaccine that is made from recombinant plasmid containing nucleocapsid protein (n) sequence constructed then expressed and purified from e. coli bacteria 
independent continuant;mycoplasma gallisepticum gene;a bacterial gene that is from mycoplasma gallisepticum.
independent continuant;nanocovax;a sars-cov-2 subunit vaccine with recombinant sars-cov-2 spike (s) protein and aluminum phosphate adjuvant
independent continuant;aves vaccine;vaccine that used for immunizing aves.
independent continuant;vaccine solvent;a vaccine component that is used to dissolve vaccine powder into liquid. the vaccine in a powder form has to be reconstituted by mixing vaccine powder with vaccine solvent before administered.
independent continuant;seasonal influenza virus vaccine foreign to usa;a seasonal influenza virus vaccine manufactured outside of the u.s.
independent continuant;hepatitis b surface antigen vaccine;a hepatitis b virus vaccine that uses recombinant hepatitis b surface antigen as the antigen
independent continuant;mixed bacterial vaccine;mixed bacterial vaccine (mbv, coley's toxins) is a historical, vaguely defined preparation of heat-inactivated streptococcus pyogenes and serratia marcescens used as non-specific immunotherapy in the treatment of cancer.
independent continuant;mva-mers-s vaccine;a mers recombinant vector made of recombinant modified vaccinia virus ankara (rmva) vaccine vector carrying full mers-cov spike glycoprotein.
independent continuant;swinepox virus vaccine vector;a poxvirus vaccine vector that uses a swinepox virus as the vector
independent continuant;mers rrbd plus alum vaccine;a mers subunit vaccine made of neutralizing monoclonal antibodiesagainst mers-cov which bind to the ribosomal binding domain (rbd) of the mers-cov s protein that was expressed by baculovirus-insect cell sf9-derived recombinant mers-cov.
independent continuant;herpes simplex virus type 1 and 2 vaccine;a vaccine that protects against herpes simplex virus type 1 and 2.
independent continuant;vrp expressing vp30;an ebola virus vaccine that is composed of vee replicon particle (vrp) encoding ebola virus vp30 protein.
independent continuant;scb-2019;a sars-cov-2 trimeric s protein subunit vaccine.
independent continuant;bovine viral diarrhea virus 2 vaccine;viral vaccine that is used to protect against bovine viral diarrhea virus 2 infection
independent continuant;poliovirus vaccine vector;a viral vaccine vector that uses a poliovirus strain
independent continuant;covid-19 dna vaccine by the university of hong kong and immuno cure 3 limited;a sars-cov-2 dna vaccine developed by university of hong kong and immuno cure 3 limited
independent continuant;pcsivgag dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcsivgag.
independent continuant;lawsonia intracellularis vaccine;a bacterial vaccine against lawsonia intracellularis infection
independent continuant;panvax;panvax is an h1n1 unadjuvanted monovalent vaccine.
independent continuant;pes dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pes. this plasmid has a cmv promoter and contains a kanamycin resistance gene.
independent continuant;ds-5670a;a sars-cov-2 mrna vaccine manufactured by daiichi sankyo co., ltd.
independent continuant;y. pestis yscf subunit vaccine;a y. pestis subunit vaccine that uses y. pestis yscf protein as antigen. pmid: 15978133.
independent continuant;diphtheria-tetanus-poliovirus vaccine foreign to usa;a diphtheria-tetanus-poliovirus vaccine manufactured outside of the u.s.
independent continuant;feline immunodeficiency virus gene;a viral gene that is from feline immunodeficiency virus.
independent continuant;turkovac;a sars-cov-2 inactivated vaccine developed by health institutes of turkey
independent continuant;menitorix;a vaccine that can be given to children after the age of 2 months up to 2 years to prevent infectious diseases caused by haemophilus influenzae type b (hib) and neisseria meningitidis group c (menc) bacteria.
independent continuant;priorix-tetra;a measles-mumps-rubella-vericella vaccine that is live attenuated and manufactured by glaxosmithkline biologicals. 
independent continuant;streptococcal vaccine;a bacterial vaccine that prevents streptococcal infections.
independent continuant;certiva;a vaccine against diphtheria, tetanus, and pertussis.
independent continuant;pseudorabies virus vaccine;a viral vaccine that protects against infection with pseudorabies virus.
independent continuant;montanide isa 50 vaccine adjuvant;mannide oleate derivative in a mineral oil solution ( seppic sa, france).
independent continuant;lentivirus vaccine vector;a viral vaccine vector that uses a lentivirus as the vector.
independent continuant;diphtheria-tetanus-pertussis-poliovirus-haemophilus b-hepatitis b vaccine foreign to usa;a diphtheria-tetanus-pertussis-poliovirus-haemophilus b-hepatitis b vaccine manufactured outside of the u.s.
independent continuant;papillomaviridae vaccine;a vaccine that is used against an infection by a pathogen under papillomaviridae.
independent continuant;c. posadasii subunit gel1 protein vaccine;a coccidioides vaccine that contains c. posadasii subunit gel1 protein
independent continuant;megan vac1;megan vac1 is a salmoneela vaccine that consists of a double gene-deleted s. enterica serovar typhimurium strain and is designed for protection of broilers to reduce salmonella contamination.
independent continuant;vat00002;a stabilised pre-fusion sars-cov-2 spike protein vaccine produced in a baculovirus expression system and manufactured by sanofi pasteur and glaxosmithkline
independent continuant;advax-cpg;advax-cpg is a combination adjuvant that includes an inulin-based polysaccharide (advax) and a cpg oligodeoxynucleotide (odn)
independent continuant;pcmv-beta dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmv-beta. this plasmid is 7164 base pairs in length and contains a cmv promoter and ampicllin resistance gene.
independent continuant;myxoma virus vaccine vector;a viral vaccine vector that uses a myxoma virus strain
independent continuant;gallid herpesvirus 1 gene;a viral gene that is from gallid herpesvirus 1.
independent continuant;streptococcus agalactiae vaccine;a streptococcus vaccine against streptococcus agalactiae infection.
independent continuant;je-vax;je-vax is a sterile, lyophilized vaccine for subcutaneous use, prepared by inoculating mice intracerebrally with japanese encephalitis (je) virus, nakayama-nih strain.
independent continuant;cholera toxin derived vaccine adjuvant;a microbial derivative vaccine adjuvant that is derived from cholera toxin.
independent continuant;eimeria spp. vaccine;protozoan vaccine that is used to protect against eimeria spp. (eimeria) infection
independent continuant;african swine fever virus vaccine;viral vaccine that is used to protect against african swine fever virus infection
independent continuant;acellular vaccine;acellular vaccine is a subunit vaccine that is produced by using only the antigenic part of the disease causing organism. it often requires a "booster" every few years to maintain their effectiveness. mesh term: d20.215.894.860.900.
independent continuant;azd2816;a sars-cov-2 recombinant vector vaccine by astrazeneca and oxford university against variant strain b.1.351
independent continuant;brucella abortus recombinant vector vaccine;a b. abortus vaccine that uses a recombinant vector. 
independent continuant;diphtheria-tetanus-pertussis-poliovirus vaccine foreign to usa;a diphtheria-tetanus-pertussis-poliovirus vaccine manufactured outside of the u.s.
independent continuant;aav5-rbd-s;a sars-cov-2 recombinant viral vector vaccine by biocad
independent continuant;campylobacter fetus vaccine;a campylobacter bacterial vaccine that is used to protect against campylobacter fetus infection
independent continuant;covid-19 subunit vaccine by pt bio farma;a sars-cov-2 subunit vaccine by pt bio farma
independent continuant;sincp b-gal dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label sincp b-gal. this plasmid contains a cmv promoter.
independent continuant;typhoid-paratyphoid vaccine;a salmonella vaccine against both typhoid caused by s. typhi and paratyphoid caused by s. paratyphi.
independent continuant;leishmania infantum vaccine;a vaccine that protects against leishmania infantum.
independent continuant;psin-cmv-vac dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psin-cmv-vac. the promoter is cmv.
independent continuant;mvtt vaccine vector;a vaccinia virus vector that uses the mvtt vaccine strain as the vector. mvtt is an attenuated vaccine strain. 
independent continuant;pjw4304 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pjw4304. this plasmid is 5132 base pairs in length and contains a cmv promoter.
independent continuant;pdnavacc dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pdnavacc.
independent continuant;yersinia enterocolitica vaccine;a vaccine that protects against yersinia enterocolitica.
independent continuant;encephalomyelitis-influenza-west nile virus eastern & western, killed virus vaccine (usda: 13w5.20);a horse encephalomyelitis-influenza-west nile virus vaccine that is inactivated and manufactured by wyeth pharmaceuticals inc. 
independent continuant;m-m-r i;a vaccine used to protect against measles, mumps, and rubella for 12-15 month-old individuals.
independent continuant;rabies virus gene;a viral gene that is from rabies virus.
independent continuant;rehydragel hpa vaccine adjuvant;an aluminum vaccine adjuvant that is a synthetic oxyhydroxide of aluminum (aluminum hydroxide) prepared by acid-base precipitation.
independent continuant;rabbit hemorrhagic disease virus vaccine;a viral vaccine that protects against infection with rabbit hemorrhagic disease virus
independent continuant;mvvac2-mers-sols vaccine;a mers recombinant vector made of mvvac2 (measle virus) expressing a soluble, truncated version of spike glycoprotein of mers-cov in its full length cloned into the mvvac2 genome and rescued.
independent continuant;vaccine antigen;the vaccine component that is used as antigen to produce an immune responce protect against the specific pathogen or disease.
independent continuant;flaviviridae vaccine;a vaccine that is used against an infection by a pathogen under flaviviridae.
independent continuant;salmonella typhi gene;a bacterial gene that is from salmonella typhi.
independent continuant;rq3013;a sars-cov-2 rna vaccine by walvax biotechnology and shanghai rnacure biopharma
independent continuant;mers england1 s1 protein subunit vaccine;a mers dna vaccine made of plasmid that encoded s1 subunit only
independent continuant;pcdna dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna.
independent continuant;shiga toxin-producing e. coli vaccine;an e. coli vaccine against shiga toxin-producing e. coli (stec) infections
independent continuant;af03 vaccine adjuvant;an emulsion vaccine adjuvant containing 2.5% squalene.
independent continuant;nontypeable h. influenzae hap protein vaccine;a subunit nontypeable h. influenzae vaccine that uses hap protein.
independent continuant;flu-imune;a trivalent inactive influenza virus vaccine.
independent continuant;recombinant yersinia rv10 vaccine;a y. pestis vaccine that uses the recombinant v10 (rv10), a variant (lacking residues 271 to 300) of yersinia pestis lcrv. pmid: 16861680.
independent continuant;vsa-1 vaccine adjuvant;vsa-1 is prepared by derivatizing a natural momordica saponin in one chemical step. vsa-1 is chemically more stable than qs-21. vsa-1 is much less toxic than qs-21. the momordica saponins are from sustainable sources and widely available.
independent continuant;sindbis virus vaccine;a viral vaccine against infection of an sindbis virus.
independent continuant;pbc12/cmv/il-2 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pbc12/cmv/il-2.
independent continuant;e. coli vaccine vector;a bacterial vaccine vector that uses an e. coli strain
independent continuant;wrg/ben dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label wrg/ben. this plasmid is based off of pwrg7077. it contains a cmv promoter and a kanamycin resistance gene.
independent continuant;pabb-crs2 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pabb-crs2. this plasmid is a derivative of pcvd442 and contains a chloramphenicol resistance gene.
independent continuant;borreliella vaccine;a vaccine that is used against an infection by a pathogen under borreliella.
independent continuant;toxoid vaccine;a vaccine containing a toxoid, used to protect against toxins produced by certain bacteria. a toxoid (also called inactivated toxin) is a processed toxin that has been treated by chemical means, heat, or irradiation and is no longer capable of causing disease.
independent continuant;mipsco-mrna-rbd-1;a sars-cov-2 rna vaccine by the university of melbourne.
independent continuant;m-m-vax;a measles-mumps vaccine that is manufactured by merck and used for human. 
independent continuant;ad5-ncov;a sars-cov-2 vaccine made from a recombinant adinvorius type-5 expressing sars-cov-2 s protein.
independent continuant;hepatitis d virus vaccine;a viral vaccine that protects against infection with hepatitis d virus.
independent continuant;fungal vaccine;a vaccine that targets against a fungus infection.
independent continuant;covid-19 aapc vaccine;a sars-cov-2 recombinant vector vaccine employing the lentiviral vector system and developed by shenzhen geno-immune medical institute.
independent continuant;pbluescript dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pbluescript.
independent continuant;feline infectious peritonitis virus vaccine;viral vaccine that is used to protect against feline infectious peritonitis virus infection
independent continuant;rh109;a sars-cov-2 rna vaccine by wuhan recogen biotechnology co., ltd.
independent continuant;psectag2a dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psectag2a. this plasmid is 5159 base pairs in length and contains a cmv promoter and ampicillin reisistance gene.
independent continuant;virmugen;a gene that once deleted, would make an attenuated microbe that can be used as a live attenuated vaccine against virulent pathogen.
independent continuant;recombinant vector vaccine;a vaccine that uses a modified virus or bacterium to deliver genes that code for microbial antigens to cells of the body.
independent continuant;h2o2-killed vaccine;an inactivation vaccine that is prepared by h2o2 inactivation.
independent continuant;fp85a;a tb vaccine that uses attenuated fowlpox strain fp9 to express mycobacterial mycolyl transferase ag85a.
independent continuant;tevax vaccine;an inactive vaccine used to prevent tetanus.
independent continuant;entamoeba histolytica vaccine;a vaccine that protects against entamoeba histolytica.
independent continuant;spt (antigen formulation);spt is an emulsion vaccine adjuvant that is an emulsion of squalane (5%), tween 80( 0.2%), pluronic l121( 1.25%), phosphate-buffered saline ph 7.4, and antigen.
independent continuant;aluminum phosphate vaccine adjuvant;an aluminum vaccine adjuvant that is aluminum phosphate.
independent continuant;live attenuated brucella melitensis vaccine;live attenuated brucella vaccine is a live attenuated vaccine that protects against a brucella melitensis infection.
independent continuant;parasite protein;a protein from a parasite
independent continuant;v1jns dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label v1jns. this plasmid contains the human cmv promoter, enhancer and intron a as well as the polyadenylation sequences of bovine growth hormone.
independent continuant;fluenz;fluenz is a seasonal trivalent live attenuated influenza vaccine (laiv) administered intranasally. the vaccine contained a/california/07/2009 (h1n1) pdm09-like strain, a/victoria/361/2011 (h3n2)-like strain, and b/massachusetts/2/2012-like strain.
independent continuant;rehydragel lv vaccine adjuvant;an aluminum hydroxide vaccine adjuvant that is a low visosity aluminum hydroxide gel.
independent continuant;ad5.mers-s1 vaccine;a mers recombinant vector vaccine made of a recombinant adenoviral vector encoding the the s1 extracellular domain of s protein
independent continuant;gx-19;a sars-cov-2 dna vaccine expressing the sars-cov-2 s protein
independent continuant;fluogen;influenza virus vaccine is used to prevent infection caused by influenza virus types a and b.
independent continuant;subcutaneous route;a route of administration that is loacted in the hypodermis (subcutaneous tissue) region. 
independent continuant;listeria monocytogenes gene;a bacterial gene that is from listeria monocytogenes.
independent continuant;licensed human vaccine;a licensed vaccine with license for human use.
independent continuant;murine leukemia viral vector vaccine;a viral vaccine vector that uses a murine leukemia virus as the vaccine vector
independent continuant;arlacel a vaccine adjuvant;a synthetic vaccine adjuvant that is an emulsifier called arlacel a.
independent continuant;pvsripo vaccine vector;a recombinant viral vaccine vector that uses pvsripo, a recombinant nonpathogenic polio-rhinovirus chimera. pvsripo is an engineerable oncolytic virus whereas its internal ribosomal entry site element can be substituted to demolish its cytopathogenic effect. pvsripo has a natural inherent tropism for antigen-presenting cells (including dendritic cells and macrophages) due to the presence of the cd-155 receptor on their cellular surfaces. this enables it of inducing cd8+ t-cell mediate immune responses.
independent continuant;pcdl-sra296 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdl-sra296. this plasmid is 3700 base pairs in length and contains a sralpha promoter.
independent continuant;chlamydophila pneumoniae vaccine;a chlamydia vaccine that protects against chlamydophila pneumoniae.
independent continuant;bordetella pertussis bpze vaccine vector;a bacterial vaccine vector using a live attenuated bordetella pertussis bpze as a vaccine vector.
independent continuant;fungus protein;a protein from fungus
independent continuant;pcdna3.1/v5-his dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna3.1/v5-his. this plasmid has a cmv promoter.
independent continuant;aeromonas hydrophila vaccine;a aeromonas vaccine that protects against aeromonas hydrophila.
independent continuant;salmonella vaccine;a bacterial vaccine that protects against infections by various salmonella species.
independent continuant;yersinia ruckeri gene;a bacterial gene that is from yersinia ruckeri.
independent continuant;in-b009;a sars-cov-2 subunit vaccine by hk inno.n corporation
independent continuant;licensed vaccine;a vaccine that is licensed for commercial use.
independent continuant;hantavirus vaccine;a vaccine that protects against hantavirus.
independent continuant;rlm/iglc;seven f. tularensis proteins including iglc (rlm/iglc) were expressed in recombinant l. monocytogenes (rlm) vaccines. these 7 f. tularensis proteins are: acpa, bfr, dnak, groel, iglc, pld and katg from schus4 strain.
independent continuant;conjugate vaccine;conjugate vaccine is vaccine that conjugates/links antigens to the molecules that form the outer coat of disease-causing bacteria to promote an immune response.
independent continuant;vsa-2 vaccine adjuvant;vsa-2 is a vaccine adjuvant that is synthesized by derivatizing a natural momordica saponin in one step. vsa-2 is chemically stable. vsa-2 is much less toxic than qs-21. vsa-2 is more th1-biased than qs-21. momordica saponins are isolated from widely available and sustainable sources.
independent continuant;recombinant hiv gp120 with adjuvant nanoemulsion;a hiv vaccine that is made of recombinant hiv gp120 protein adjuvanted with the adjuvant nanoemulsion. pmid: 18260780.
independent continuant;pngvl3 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pngvl3. this plasmid has a cmv promoter and kanamycin and ampicillin resistance genes.
independent continuant;suvaxyn aujeszky;a vaccine that is made of a tk-negative (tk -) and gi/ge-negative (gi/ge -) pseudorabies virus (prv) mutant to protect pigs against aujeszky's disease. aujeszky's disease is also known as pseudorabies. it is a disease primarily of pigs and is caused by porcine herpesvirus 1. this disease is characterized by respiratory, reproductive and nervous signs.
independent continuant;parainfluenza virus vaccine;a viral vaccine that protects against infection with parainfluenza virus.
independent continuant;heplisav-b;a hepatitis b surface antigen viral vaccine that utilizes a cytidine-phosphate-guanosine oligodeoxynucleotide (cpgodn) 1018, as an adjuvant.
independent continuant;complete freunds adjuvant;is a freund's emulsfied oil adjuvant that contains inactivated and dried mycobacteria, usually mycobacterium tuberculosis (the pathogenic agent of tuberculosis).
independent continuant;l. monocytogenes lm1-2 vaccine vector;a listeria monocytogenes vaccine vector that uses the highly attenuated lm1-2 strain 
independent continuant;edwardsiella ictaluri gene;a bacterial gene that is from burkholderia pseudomallei.
independent continuant;rabie-vax;a vaccine for indivuduals who at risk or recently exposed to rabies.
independent continuant;vaccination site;the site that is the part of the host body and the entrance point where a vaccine is administered. 
independent continuant;2011 2012 trivalent inactivated vaccine (a/california/7/09 (h1n1), a/perth /16/2009 (h3n2), and b/brisbane/60/2008);2010-2011 trivalent seasonal inactivated influenza vaccine 2010 consisting of influenza a virus (a/california/7/2009(h1n1)), influenza a virus (a/texas/50/2012(h3n2)), influenza b virus (b/brisbane/60/2008)
independent continuant;vcl-1632 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vcl-1632. this plasmid contains a cmv promoter, kanamycin resistance gene, the murine constant region sequence, a translational enhancer, the murine igg2a heavy-chain sequence, and a translation terminator. this plasmid is derived from puc-18.
independent continuant;vaxstrate;an anti-reproductive vaccine for cattle. the vaccine is based on the established principle that antibodies to the hypothalamic releasing hormone, gonadotrophin releasing hormone (gnrh) block the action of gnrh on pituitary secretion of luteinizing hormone and follicle stimulating hormone, leading to gonadal atrophy in mammals. the vaccine comprises an immunogenic gnrh:ovalbumin conjugate formulated in a novel double adjuvant system and is administered in a two-dose treatment regimen. 
independent continuant;haemophilus parasuis vaccine;bacterial vaccine that is used to protect against haemophilus parasuis infection
independent continuant;pika recombinant covid-19 vaccine;a sars-cov-2 subunit vaccine by yisheng biopharma
independent continuant;influenza virus vaccine;a viral vaccine that protects against infection with influenza virus.
independent continuant;yellow fever 17d vaccine vector;a viral vaccine vector that uses yellow fever vaccine strain 17d as the vector.
independent continuant;yf 17dd-yfv;a yf-17dd vaccine t hat is manufactured by bio-manguinhos
independent continuant;rdna-expressed s sars protein vaccine;a sars dna vaccine made from rdna-expressed ectodomain of the s protein.
independent continuant;varicellovirus vaccine;a vaccine that is used against an infection by a pathogen under varicellovirus.
independent continuant;stamaril;it is live attenuated yfv vaccine strain 17d manufactured in china, france, senegal, and the usa. in powder and solvent for suspension for injection in pre-filled syringe.
independent continuant;cholera toxin b subunit vaccine adjuvant;a microbial derivative vaccine adjuvant made of the b subunit of the cholera toxin from vibrio cholerae.
independent continuant;colorectal cancer vaccine;a cancer vaccine that is used against colorectal cancer
independent continuant;sii bivalent;a sars-cov-2 bivalent protein subunit vaccine by novavax containing antigen for both the ancestral strain and b.1.351 (beta) variant.
independent continuant;trichomonas foetus vaccine;protozoan vaccine that is used to protect against tritrichomonas suis infection
independent continuant;kd-414;a sars-cov-2 inactivated vaccine developed by km biologics co., ltd.
independent continuant;freunds emulsified oil adjuvant;an emulsion vaccine adjuvant that consists of a water-in-oil emulsion of aqueous antigen in paraffin (mineral) oil of low specific gravity and low viscosity. it is named after jules t. freund (1890-1960), hungarian-born american immunologist. it is a water in oil emulsion.
independent continuant;rabies virus vaccine;a viral vaccine that protects against infection with rabies virus.
independent continuant;s. sonnei strain wrss1;a stable attenuated shigella sonnei strain with virg mutation. pmid: 9712824.
independent continuant;yersiniaceae vaccine;a vaccine that is used against an infection by a pathogen under yersiniaceae.
independent continuant;pgt36 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pgt36. this plasmid is a derivative of pcdna3 and contains a cmv promoter and a kanamycin resistance gene.
independent continuant;aeromonas salmonicida vaccine;an aeromonas bacterial vaccine that is used to protect against aeromonas salmonicida infection
independent continuant;yersinia pseudotuberculosis vaccine;a bacterial vaccine that protects against infections by yersinia pseudotuberculosis.
independent continuant;chadv68-s;a sars-cov-2 chimpanzee adenovirus serotype 6 vector vaccine manufactured by gritstone oncology and the national institute of allergy and infectious diseases
independent continuant;non-replicating adenovirus accine vector;an adenovirus vaccine vector that is not able to replicate.
independent continuant;dryvax;a vaccinia virus vaccine that is a freeze-dried calf lymph smallpox vaccine, specifically, dryvax is a live-virus preparation of vaccinia prepared from calf lymph. 
independent continuant;haemophilus influenzae vaccine;a vaccine that protects against haemophilus influenzae.
independent continuant;covax-19;a sars-cov-2 protein subunit vaccine developed by vaxine pty ltd and cinnagen co. and adjuvanted with advax
independent continuant;chlamydophila abortus vaccine;a chlamydia bacterial vaccine against c. abortus infection
independent continuant;rhabdovirus-based vaccine vector;a viral vaccine vector that uses a rhabdovirus-based viral strain as the vaccine vector
independent continuant;rvm-v001;a sars-cov-2 rna vaccine by rvac medicines
independent continuant;abo1009-dp;a sars-cov-2 rna vaccine by suzhou abogen biosciences co., ltd.
independent continuant;porcine circovirus 2 vaccine;viral vaccine that is used to protect against porcine circovirus 2 infection
independent continuant;epivaccorona;a sars-cov-2 protein subunit vaccine that relies on chemically synthesized peptide antigens of sars-cov-2 proteins, conjugated to a carrier protein and adsorbed on an aluminum-containing adjuvant (aluminum hydroxide).
independent continuant;human protein;a protein from human
independent continuant;vlpcov-01;a sars-cov-2 rna vaccine manufactured by vlp therapeutics japan, llc
independent continuant;pfspz-cvac;the fully infectious pfspz are attenuated in vivo by concomitant administration of an anti-malarial drug (chloroquine). chloroquine kills disease-associated blood stages but does not affect pre-erythrocytic (sporozoite or liver) stages, which are exposed to the host's immune system. sporozoites-induced protection is mediated by immunity against pre-erythrocytic stages.
independent continuant;cvncov;a sars-cov-2 mrna vaccine developed by curevac ag and cepi.
independent continuant;non-toxic mutant e112k of cholera toxin mct-e112k vaccine adjuvant;a microbial derived vaccine adjuvant made of e112k mc, a mutated ct created by substituting a single amino acid in the adp-ribosyltransferase active centre, glutamate to lysine at position 112.
independent continuant;covid-19 vlp vaccine by the scientific and technological research council of turkey;a covid-19 virus-like particle vaccine developed by the scientific and technological research council of turkey
independent continuant;pcmv3iss dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmv3iss. this plasmid is a eukaryotic expression vector.
independent continuant;mycoplasma vaccine;a bacterial vaccine against mycoplasma bacterial infection
independent continuant;coronavac;a sars-cov-2 whole virus vaccine made from a purified inactivated sars-cov-2 virus.
independent continuant;intragastric route;route of administration that located in the stomach, so that the material is taken into body through stomach directly. 
independent continuant;infectious hematopoietic necrosis virus vaccine;a vaccine that protects against infectious hematopoietic necrosis virus.
independent continuant;titermax gold vaccine adjuvant;titermax gold is an emulsion vaccine adjuvant which is a water-in-oil adjuvant with crl-8300 (a block copolymer), squalene, and sorbitan monooleate.
independent continuant;retroviral vaccine vector;a viral vaccine vector that uses a retroviral strain
independent continuant;dna and adenoviral vector ad5 expressing siv gag protein;a vaccine combination that includes a dna vaccine and a recombinant adenovirus ad5 expressing the same codon-optimized siv gag gene. the dna vaccine is used for priming, and the ad5 vaccine is used for boosting. pmid: 11797011.
independent continuant;vaccine residual protein from cell culture;a cell culture residual in vaccine that is residual protein from cell culture. 
independent continuant;diphtheria-tetanus-pertussis-poliovirus-haemophilus b vaccine foreign to usa;a diphtheria-tetanus-pertussis-poliovirus-haemophilus b vaccine manufactured outside of the u.s
independent continuant;ptpa-pa63 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label ptpa-pa63.
independent continuant;uv-inactivated sars + tlr agonist vaccine;a sars inactivated vaccine made from sars-cov inactivated by ultraviolet radiation and a toll-like receptor agonist adjuvant is added to prevent eosinophilic immunopathology
independent continuant;actinobacillus pleuropneumoniae hs93tox vaccine vector;a bacterial vaccine vector using the hs93tox- mutant of the serovar 7 strain of actinobacillus pleuropneumoniae. this mutant lacks the genes encoding the toxin apxa and the post-translational activating protein apxc, but still has genes required for secretion, making it a good vector. 
independent continuant;interleukin-2 vaccine adjuvant;a cytokine vaccine adjuvant that includes il-2.
independent continuant;betuvax-cov2;a sars-cov-2 protein subunit vaccine manufactured by human stem cell institute
independent continuant;monophosphoryl lipid a vaccine adjuvant;a microbial derivative vaccine adjuvant derived from the lipopolysaccharide (lps) of salmonella minnesota r595.
independent continuant;aeromonas vaccine;a bacterial vaccine that is used to protect against aeromonas bacterial infection
independent continuant;brucella abortus conjugate vaccine;a b. abortus vaccine that uses a conjugate vaccine format
independent continuant;mva-sars-2-st;a sars-cov-2 recombinant viral vector vaccine by the german center for infection research
independent continuant;toxin;a toxin (from ancient greek: toxikon) is a poisonous substance produced within living cells or organisms. man-made substances created by artificial processes are thus excluded. 
independent continuant;skycovione;a sars-cov-2 protein subunit vaccine manufactured by sk bioscience co., ltd., and equipped with an aluminum hydroxide adjuvant
independent continuant;pubiq dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pubiq. this plasmid is derived from pgem3 and contains a cmv promoter and an ampicillin resistance gene.
independent continuant;bluetongue virus vaccine;viral vaccine that is used to protect against bluetongue virus infection
independent continuant;albumin-heparin microparticles vaccine adjuvant;a particulate antigen delivery system that is albumin-heparin microparticles vaccine adjuvant that is prepared from albumin and heparin stabilized by cross-linking reaction with edc.
independent continuant;p. falciparum rts,s/as02a;rts,s/as02a is a pre-erythrocytic vaccine candidate based on plasmodium falciparum circumsporozoite surface antigen. pmid: 15488216.
independent continuant;plasmodium falciparum vaccine;a malaria vaccine that protects against malaria caused by plasmodium falciparum.
independent continuant;poxvirus vaccine vector;a viral vaccine vector that uses an poxvirus as the vector.
independent continuant;tritanrix;active immunzation against diphtheria, tetanus, pertussis and hepatitis b (hbv) in infants from 6 weeks onwards
independent continuant;borna disease virus vaccine;a viral vaccine that protects against infection with borna disease virus
independent continuant;dl-pgl (polyester poly (dl-lactide-co-glycolide)) vaccine adjuvant;a synthetic vaccine adjuvant that is plga, which has been used in the controlled delivery of peptide drugs.
independent continuant;cholera vaccine, usp;an active immunization against cholera, indicated only for individuals traveling to or residing in countries where cholera is endemic or epidemic.
independent continuant;aks-452;a sars-cov-2-rbd-fc fusion protein designed to induce or boost a th1/th2 mixed immune response in patients against the receptor binding domain (rbd) of the novel coronavirus spike protein.
independent continuant;varicella-zoster virus live vaccine;a varicella-zoster virus vaccine that is live attenuated.
independent continuant;coh04s1;a synthetic modified vaccinia ankara (mva)-based sars-cov-2 vaccine
independent continuant;edwardsiella tarda gene;a bacterial gene that is from edwardsiella tarda.
independent continuant;orthopoxvirus vaccine;a vaccine that is used against an infection by a pathogen under orthopoxvirus.
independent continuant;equine influenza vaccine;an influenza virus vaccine against equine influenza viral infection
independent continuant;yeast protein cell culture residual in vaccine;a cell culture residual in vaccine that is yeast protein.
independent continuant;adamantylamide dipeptide vaccine adjuvant;a synthetic vaccine adjuvant, adamantylamide dipeptide (addp) is the desmuramyl analog of mdp.
independent continuant;thimerosal vaccine preservative;vaccine preservative that has thimerosal as part.
independent continuant;montanide isa 206 vaccine adjuvant;a water-dispersed liquid nanoparticle combined with an immuno-stimulating compound
independent continuant;vpm1002;a tb vaccine that recombinant bcg strain with the replacment of its urease c encoding gene with the listeriolysin encoding gene from listeria monocytogenes.
independent continuant;t. cruzi par2 protein vaccine;a t. cruzi subunit vaccine that uses t. cruzi par2 protein as protective antigen.
independent continuant;sucrose albumin cell culture residual in vaccine;a cell culture residual in vaccine that is sucrose albumin.
independent continuant;psectag2 c dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psectag2 c. this plasmid is 5167 base pairs long, has a cmv promoter and ampicillin and zeocin resistance genes.
independent continuant;mf59-adjuvanted sars-cov-2 sclamp vaccine;an mf59-adjuvanted sars-cov-2 subunit vaccine based on recombinant sars-cov-2 spike glycoprotein stabilised in a pre-fusion conformation by a novel molecular clamp (spike glycoprotein-clamp [sclamp])
independent continuant;202-cov;a sars-cov-2 subunit vaccine manufactured by shanghai zerun biotechnology, walvax biotechnology, and cepi
independent continuant;vrp-sars-n vaccine;a sars recombinant vector vaccine made from venezuelan equine encephalitis replicons (vrp) encoding a sars-cov cd4+ t cell epitope vaccinated intranasally. crosslisted as mers vaccine (violinid:5789). efficacy higher intranasally than subcutaneously.
independent continuant;avian paramyxovirus vaccine;viral vaccine that is used to protect against avian paramyxovirus infection
independent continuant;vaxigrip;vaxigrip is an influenza virus vaccine that is manufactured by 'sanofi pasteur limited.
independent continuant;trihibit;a vaccine for diphtheria, haemophilus influenzae, pertussis, and tetanus diseases.
independent continuant;measles-rubella vaccine;yh
independent continuant;mrna-1273.351;a sars-cov-2 lipid nanoparticle (lnp)-encapsulated mrna-based vaccine that encodes for a full-length, prefusion stabilized s protein of the sars-cov-2 b.1.351 variant
independent continuant;live attenuated bacterial vaccine;a bacterial vaccine that is live and attenuated
independent continuant;salmonella typhi vaccine vector;a bacterial vaccine vector that uses a salmonella typhi strain
independent continuant;unair inactivated covid-19 vaccine;a sars-cov-2 inactivated vaccine developed by airlangga university
independent continuant;ltk72 vaccine adjuvant;a microbial derivative vaccine adjuvant that is a mutant form of heat-labile escherichia coli enterotoxin (lt) that contains a substitution ala arg in position 72 of the a subunit.
independent continuant;pneumo 23;a polyvalent pneumococcal vaccine used to protectsagainst serious infection (e.g., meningitis, bacteria in the blood) due to streptococcus pneumoniae, and it is manufactured by sanofi pasteur.
independent continuant;iibr-100;a rvsv-sars-cov-2-s vaccine developed by the israel institute for biological research (iibr)
independent continuant;viral vaccine;a vaccine that targets against a viral disease.
independent continuant;dna and mva encoding me-trap;a vaccine that contains dna and modified vaccinia virus ankara (mva) encoding thrombospondin-related adhesion protein (trap) with a multiple-epitope string me (me-trap). this vaccine is used with a prime-boost regime by dna priming and mva boosting. pmid: 16988273.
independent continuant;brucella suis gene;a brucella gene that is from b. suis.
independent continuant;ndv-hxp-s;a sars-cov-2 recombinant viral vector vaccine by mahidol university
independent continuant;meruvax i;hpv77/de5 strain
independent continuant;pclf4;pclf4 is a bacillus anthracis vaccine that contains the n-terminal region (amino acids [aa] 10-254) of bacillus anthracis lf cloned into the pci expression plasmid.
independent continuant;haemophilus vaccine;a bacterial vaccine that protects against infection with haemophilus.
independent continuant;yersinia vaccine;a bacterial vaccine that protects against yersinia bacterial infection.
independent continuant;vibrio vaccine;a bacterial vaccine against vibrio infection
independent continuant;simian immunodeficiency virus vaccine;a viral vaccine that prevents against infection with simian immunodeficiency virus.
independent continuant;mycobacterium tuberculosis vaccine;a mycobacterium vaccine that protects against mycobacterium tuberculosis.
independent continuant;um-3004 vaccine adjuvant;um-3004 is a small molecule tlr7/8 agonist that can stimulate th1-biased immune profile.
independent continuant;yersinia pestis vaccine;a bacteria vaccine that prevents against yersinia pestis infection that causes plague.
independent continuant;prsc dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label prsc.
independent continuant;covepit;a sars-cov-2 subunit vaccine by ose immunotherapeutics
independent continuant;dna vaccine expressing sgp;a dna vaccine that encodes for a secreted form of ebola virus gp protein.
independent continuant;td-rix;a vaccine used to prevent diphtheria and tetanus in individuals over 6 years of age.
independent continuant;apmv-3 vaccine vector;a viral vaccine vector that uses an avian paramyxovirus strain
independent continuant;brucella suis strain 2;an orally administrable brucellosis vaccine that was was developed in china. it is effective for oral vaccination of sheep, goats, cattle and pigspmid: 3541425.
independent continuant;edwardsiella ictaluri vaccine;an edwardsiella bacterial vaccine that is used to protect against edwardsiella ictaluri infection
independent continuant;as02a vaccine adjuvant;as02a contains 50 ug mpl and 50ug qs21, 250ul of sb62 (oil/water emulsion) in phosphate buffered saline (pbs) per volume of 0.5 ml
independent continuant;tetanus toxoid vaccine;a clostridium tetani vaccine that consists of formaldehyde inactivated tetanospasmin (aka tetanus toxoid).
independent continuant;chadv68-s;a synthetic modified vaccinia ankara (mva)-based sars-cov-2 vaccine
independent continuant;v591;a sars-cov-2 vaccine candidate that uses a measles virus vector platform, and is made by merck. development of the vaccine was discontinued on january 25, 2021.
independent continuant;chicken anemia virus vaccine;viral vaccine that is used to protect against chicken anemia virus infection
independent continuant;pci-tpa dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pci-tpa. this plasmid contains the n-terminal signal sequence of tpa.
independent continuant;newcastle disease virus vaccine vector;a viral vaccine vector that uses a newcastle virus strain
independent continuant;human serum albumin;the serum albumin that is part of human
independent continuant;brucella abortus s19 with p39 deletion;a b. abortus vaccine that is recombinant b. abortus strain 19 vaccine with the p39 gene deletion.
independent continuant;egyvax;a sars-cov-2 inactivated vaccine developed by eva pharma.
independent continuant;arthritis vaccine;a vaccine that prevents or treats arthritis.
independent continuant;riemerella anatipestifer vaccine;bacterial vaccine that is used to protect against riemerella anatipestifer infection
independent continuant;interleukin-1b vaccine adjuvant;a cytokine vaccine adjuvant that includes il-1b.
independent continuant;rabavert;rabavert rabies vaccine is a sterile, freeze-dried vaccine obtained by growing the fixed-virus strain flury low egg passage (lep) in primary cultures of chicken fibroblasts.
independent continuant;bovine serum cell culture residual in vaccine;a cell culture residual in vaccine that is bovine serum.
independent continuant;bacterial and viral combination vaccine;a combination vaccine that is used against both bacterial and viral infections.
independent continuant;siv based lentivirus vaccine vector;a lentivirus vaccine vector that uses a siv strain as the vector
independent continuant;t. cruzi dna vaccine encoding g4;a t. cruzi dna vaccine that uses a dna plasmid pgfp expressing t. cruzi g4 protein.
independent continuant;grad-cov2;a sars-cov 2 recombinant viral vector using gorilla adenovirus that encodes for sars-cov-2 spike protein.
independent continuant;covid-19 subunit vaccine by hipra;a sars-cov-2 protein subunit vaccine by laboratorios hipra
independent continuant;plasmodium yoelii vaccine;a malaria vaccine that protects against malaria caused by plasmodium yoelii.
independent continuant;dna and poxvirus priming-boosting siv vaccine;a siv vaccine that is composed of a dna vaccine and a poxvirus vector expressing the same siv antigens. pmid: 15258286.
independent continuant;diabetes vaccine;a vaccine that prevents or treats diabetes.
independent continuant;mannheimia haemolytica vaccine;bacterial vaccine that is used to protect against mannheimia haemolytica infection
independent continuant;quail pox vaccine;a pox vaccine for quail pox
independent continuant;pdonr221 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pdonr221. the plasmid length is 4762.
independent continuant;infanrix penta;a combination vaccine against diphtheria, tetanus, pertussis, hepatitis b, and poliovirus.
independent continuant;ad5-tricov/mac;a sars-cov-2 replication deficient human adenovirus vector vaccine expressing the spike, nucleocapsid and rna polymerase proteins.
independent continuant;salmonella typhimurium vaccine;a bacterial vaccine that protects against infections by salmonella typhimurium species.
independent continuant;um-3005 vaccine adjuvant;um-3005 is a small molecule tlr7/8 agonist that can stimulate th1-biased immune profile.
independent continuant;rf1 + rv vaccine;a y. pestis subunit vaccine that uses recombinant f1 and v antigens. pmid: 312163.
independent continuant;bordetella pertussis vaccine;a bacterial vaccine that prevents against bordetella pertussis infection that causes pertussis or whooping cough.
independent continuant;bacillus anthracis gene;a bacterial gene that is from bacillus anthracis.
independent continuant;pcdna3.1/v5-his-topo dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna3.1/v5-his-topo. this plasmid is 5523 base pairs in length and contains a cmv promoter and ampicillin resistance gene.
independent continuant;bovine respiratory syncytial virus gene;a viral gene that is from bovine respiratory syncytial virus.
independent continuant;streptococcus suis vaccine;a bacterial vaccine against streptococcus suis infection
independent continuant;monkeypox virus vaccine;viral vaccine that is used to protect against monkeypox virus infection
independent continuant;1v270 vaccine adjuvant;iv270 is a low molecular weight tlr7 agonist conjugated to a phospholipid and is a highly potent and stable immune activator
independent continuant;brucella abortus strain rb51 vaccine vector;a bacterial vaccine vector that uses b. abortus vaccine strain rb51 as the vector.
independent continuant;wboa from b. abortus strain 2308;a brucella abortus gene that has the name wboa and comes from strain 2308. 
independent continuant;orimune vaccine;monovalent vaccine agianst poliomyelitis for infants 6-12 weeks of age, all immunized children up to 18 years of age, and high risk adults.
independent continuant;sars ad s/n vaccine;a sars recombinant vector vaccine made of combination of two adenovirus-based vectors, one expressing the nucleocapsid (n) and the other expressing the spike (s) protein
independent continuant;prc/rsv dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label prc/rsv. this plasmid is 5224 base pairs in length and contains a rsv ltr promoter and ampicillin resistance gene.
independent continuant;murapalmitine vaccine adjuvant;a synthetic vaccine adjuvant called murapalmitine.
independent continuant;streptococcus gordonii vaccine vector;a bacterial vaccine vector using a live attenuated streptococcus gordonii vaccine vector.
independent continuant;murametide vaccine adjuvant;a synthetic vaccine adjuvant made of murametide that has adjuvant activity similar to mdp.
independent continuant;bovine herpesvirus 1 vaccine;viral vaccine that is used to protect against bovine herpesvirus 1 infection
independent continuant;porcine adenovirus 3 vaccine vector;an adenovirus vaccine vector that uses a porcine adenovirus 3 strain
independent continuant;covid-19 subunit vaccine by national vaccine and serum institute of china;a sars-cov-2 subunit vaccine developed by the national vaccine and serum institute of china
independent continuant;intranasal route;rounte of administration that located in nose.
independent continuant;mva-mers vaccine;a mers vlp vaccine made from a recombinant baculovirus co-expresssing the spike s, envelope (e), and membrane (m) proteins of mers.
independent continuant;j-vax;an inactivated japanese encephalitis vaccine (jvax *) for use by certain travelers to and expatriates in asia.
independent continuant;il-15 vaccine adjuvant;a cytokine vaccine adjuvant that uses the adjuvant effect of cytokine il-15.
independent continuant;abncov2;a covid-19 virus-like particle vaccine developed by radboud university
independent continuant;staphylococcus aureus bacterin vaccine;a s. aureus vaccine that uses bacterin as the protective antigen. 
independent continuant;s. flexneri 2a strain cvd 1207;a live attenuated shigella flexneri 2a vaccine with specific deletion mutations in virg, sen, set, and guaba.
independent continuant;viral haemorrhagic septicaemia virus vaccine;a viral vaccine against infection of a viral haemorrhagic septicaemia virus.
independent continuant;enterotoxigenic e. coli vaccine;an e. coli vaccine against enterotoxigenic e. coli infections
independent continuant;vaccine stabilizer;a vaccine additive that helps to protect the vaccine from adverse conditions such as the freeze-drying process (for those vaccines that are freeze-dried) or heat.
independent continuant;pseudomonas vaccine;a bacterial vaccine that protects against infection with pseudomonas.
independent continuant;human respiratory syncytial virus vaccine;a viral vaccine that protects against infection of human respiratory syncytial virus.
independent continuant;xtendiii vaccine adjuvant;oil-based adjuvant (adjuvant xtendiii . grand laboratories, larchwood, ia)
independent continuant;papillomavirus vaccine;a viral vaccine that protects against infection with papillomavirus.
independent continuant;vaccine containing dna vaccine for priming and ad vector vaccine for boosting;a prime-boost vaccine with a dna vaccine priming that contains a ad vector vaccine for boosting
independent continuant;inactivated monovalent influenza a/h5n1 (3.75 mcg hemagglutinin [ha] a/indonesia/05/2005) split-virus (sv) vaccine (sanofi);inactivated monovalent influenza a/h5n1 (3.75 mcg hemagglutinin [ha] a/indonesia/05/2005) split-virus (sv) vaccine (sanofi)
independent continuant;pigeonpox virus vaccine;viral vaccine that is used to protect against pigeonpox virus infection
independent continuant;escherichia coli vaccine;a bacterial vaccine that prevents against escherichia coli infection.
independent continuant;nvx-cov2373;a sars-cov 2 (rsars-cov-2) subunit vaccine made of nanoparticles composed of a trimeric full-length sars-cov-2 spike glycoprotein and matrix-m1 adjuvant.
independent continuant;measles virus vaccine;a viral vaccine that protects against infection with measles virus.
independent continuant;infectious hematopoietic necrosis virus gene;a viral gene that is from infectious hematopoietic necrosis virus.
independent continuant;viral vaccine vector;a vaccine vector that uses a virus as the vector.
independent continuant;killed vaccine;whole organism vaccine that uses killed pathogen organism as its component.
independent continuant;salmonella gallinarum vaccine;a bacterial vaccine that protects against infections by salmonella enterica subsp. enterica serovar gallinarum.
independent continuant;feline calicivirus vaccine;viral vaccine that is used to protect against feline calicivirus infection
independent continuant;td polio adsorbed;a multivalent vaccine against tetanus, diphtheria, and poliomyelitis.
independent continuant;covid-19 mrna vaccine by cansino biologics;a sars-cov-2 rna vaccine by cansino biologics inc.
independent continuant;meningococcal conjugate and haemophilis b vaccine foreign to usa;a meningicoccal conjugate and haemophilis b vaccine manufactured outside of the u.s.
independent continuant;non-ionic surfactant vesicles vaccine adjuvant;a synthetic vaccine adjuvant consisting of multi-lamellar vesicles comprising a mixture of non-ionic surfactant (e.g., 1-monopalmitoyl-rac-glycerol), cholesterol and dicetyl phosphate used as a primary vaccine adjuvant for entrapped antigen.
independent continuant;dibutyl phthalate vaccine adjuvant;diester obtained by the formal condensation of the carboxy groups of phthalic acid with two molecules of butan-1-ol
independent continuant;streptococcus pneumoniae vaccine;a streptococcal vaccine that is used against s. pneumoniae infection, which causes pneumococcal diseases. 
independent continuant;yersinia enterocolitica gene;a bacterial gene that is from yersinia enterocolitica.
independent continuant;ribi vaccine adjuvant;ribi vaccine adjuvant is an emulsion vaccine adjuvant that is a stable oil-in-water emulsion.
independent continuant;clostridium tetani vaccine;a clostridium vaccine that protects against infection with clostridium tetani that causes tenanus.
independent continuant;non-infectious disease vaccine;a vaccine that prevents or treats a non-infectious disease.
independent continuant;psport-b-gal dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psport-b-gal. this plasmid contains a cmv promoter.
independent continuant;morupar;a measles-mumps-rubella vaccine that is manufactured by sanofi aventis.
independent continuant;ppa63-lamp1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label ppa63-lamp1.
independent continuant;p188 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label p188. this plasmid is a replication-defective derivative of pp1/h7.
independent continuant;psin-b-gal dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psin-b-gal. this plasmid contains a cmv promoter.
independent continuant;leishmania vaccine;a protozoan vaccine that prevents against infection with leishmania.
independent continuant;recombinant sars-cov-2 vaccine (sf9 cell);a sars-cov-2 protein subunit vaccine by west china hospital
independent continuant;fluzone intradermal trivalent;a trivalent influenza vaccine containing two strains of influenza a and one strain of influenza b for use in people 18 years to 64 years for use during the 2012-2013 season.
independent continuant;newcastle disease virus vaccine;a viral vaccine that protects aganist newcastle disease virus infection.
independent continuant;e. coli fimh with cfa and then ifa;an e. coli subunit vaccine that uses e. coli fimh adhesin protein as teh antigen, and uses the complete freund's adjuvant (cfa) in the first vaccination and the incomplete freund's adjuvant (ifa) in the boost vaccination.
independent continuant;razi cov pars;a sars-cov-2 protein subunit vaccine manufactured by the razi vaccine and serum research institute with a spike protein antigen
independent continuant;pcmv/r dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmv/r. this plasmid is a mammalian expression vector with a cmv promoter.
independent continuant;erysipelothrix rhusiopathiae vaccine;bacterial vaccine that is used to protect against erysipelothrix rhusiopathiae infection
independent continuant;measles virus vaccine vector;a viral vaccine vector that uses a measles virus strain
independent continuant;e. coli toxoid vaccine;an e. coli vaccine that uses toxoid antigen
independent continuant;dengue virus vaccine;a viral vaccine that protects against infection with dengue virus.
independent continuant;yeast extract cell culture residual in vaccine;a cell culture residual in vaccine that is from yeast extract.
independent continuant;multivalent vaccine against bacterial and viral diseases;a multivalent vaccine that is designed to immunize against at least one bacterial disease and one viral disease.
independent continuant;infanrix-hexa;a combination vaccine that protects infants from diphtheria, tetanus, pertussis (whooping cough), polio, hepatitis b and haemophilus influenzae type b (hib).
independent continuant;orf virus vaccine;viral vaccine that is used to protect against orf virus infection
independent continuant;nano-covid;a sars-cov-2 subunit vaccine containing a t-cell priming specific cocktail of coronaviruses peptides mounted on a gold nanoparticle.
independent continuant;rubella virus vaccine;a viral vaccine that protects against infection with rubella virus.
independent continuant;montanide ims 1313 vaccine adjuvant;a water-dispersed liquid nanoparticle combined with an immuno-stimulating compound
independent continuant;combination vaccine;combination vaccine is a vaccine that induces protection against multiple infectious diseases or several different serotypes of the same organism. the anitgens contained in combination vaccines are either formulated together by the manufacturer or physically mixed by a health care provider just prior to administration. both approaches require licensure. ref: baylor nw and midthum k. regulation and testing of vaccines. in: vaccines (editors: plotkin s, orenstein w, and offit p). 2008. p1624.
independent continuant;rc529-af vaccine adjuvant;an aqueous formula of the synthetic vaccine adjuvant rc529.
independent continuant;haemophilus somnus vaccine;bacterial vaccine that is used to protect against haemophilus somnus infection
independent continuant;brucella melitensis gene;a brucella gene that is from b. melitensis.
independent continuant;pcj-3 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcj-3. this plasmid has a cmv promoter and a kanamycin resistance gene.
independent continuant;pandemrix;pandemrix is an influenza vaccine for influenza pandemics, such as the h1n1 2009 flu pandemic colloquially called the swine flu. the vaccine was developed by glaxosmithkline and patented in september 2006.
independent continuant;modified vaccinia ankara (mva) virus vaccine vector;a vaccinia virus vector that uses the modified vaccinia ankara (mva) virus. 
independent continuant;pfspz-ga1;sanaria pfspz-ga1 consists of purified, aseptic, cryopreserved pf sporozoites (nf54 strain) genetically attenuated by removal of the b9 and slarp genes to halt development in the early liver stages.
independent continuant;mycoplasma gallisepticum bacterin vaccine;a mycoplasma gallisepticum vaccine that uses bacterin as the protective antigen
independent continuant;covaxin;bbv152 (also known as covaxin) is an inactivated covid-19 vaccine that is developed by bharat biotech in collaboration with the indian council of medical research.
independent continuant;muramyl dipeptide vaccine adjuvant;a synthetic vaccine adjuvant formulated to correspond to a component found in a water-soluble extract of cell walls of mycobacteria used in complete freund's adjuvant (cfa).
independent continuant;inactivation residual in vaccine;a vaccine residual that is used to inactivate bacteria and viruses or to detoxify bacterial toxins. for example, formaldehyde is a frequently used inactivation agent in vaccine preparation.
independent continuant;salmoninae vaccine;vaccine that used for immunizing salmoninae (tourts, salmons & chars )
independent continuant;monosodium glutamate stabliizer;a vaccine stablizer that is based on monosodium glutamate. 
independent continuant;threonyl muramyl dipeptide (tmdp) vaccine adjuvant;a synthetic vaccine adjuvant that is threonyl muramyl dipeptide (tmdp).
independent continuant;prime-boost vaccine;a vaccine that contains one vaccine for priming and at least one other vaccine for boosting. 
independent continuant;pcmvi-ub dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmvi-ub. this plasmid was built from pcmv-5 and contains a cmv promoter.
independent continuant;cationic liposomal vaccine adjuvant dda:tdb;a liposome-based vaccine adjuvant that have a positive surface charge.
independent continuant;tetanus toxoid (for boost use only) by sanofi pasteur inc;a tetanus vaccine manusfactured by sanofi pasteur inc. that is only for booster use (not recommended for primary immunization)
independent continuant;mrkad5 hiv-1 gag/pol/nef;the mrk adenovirus type 5 human immunodeficiency virus type 1 clade b gag/pol/nef vaccine is a replication-incompetent adenovirus type 5-vectored vaccine that elicits cell-mediated immunity against conserved human immunodeficiency virus proteins.
independent continuant;herpesvirus vaccine;a viral vaccine that protects against infection with herpesvirus.
independent continuant;avian encephalomyelitis virus vaccine;viral vaccine that is used to protect against avian encephalomyelitis virus infection
independent continuant;imovax rabies (usa);the imovax 9 rabies vaccine is a sterile, stable, freeze-dried 10 suspension of rabies virus prepared from strain pm-1503-3m.
independent continuant;uv-inactivated sars vaccine;a sars inactivated vaccine made from sars-cov inactivated by ultraviolet radiation
independent continuant;fluzone intradermal trivalent;kallan roan, oliver he
independent continuant;vaxfectin vaccine adjuvant;an equimolar mixture of the cationic lipid gap-dmorie [( )-n-(3-aminopropyl)-n,n-dimethyl-2,3-bis(cis-9-tetradecenyloxy)-1-propanaminium bromide)] and a neutral colipid dpype (1,2-diphytanoyl-sn-glydero-3-phosphoethanolamine)
independent continuant;reoviridae vaccine;a vaccine that is used against an infection by a pathogen under reoviridae.
independent continuant;t. cruzi dna vaccine encoding crp-10;a t. cruzi dna vaccine that uses a dna plasmid pgfp expressing t. cruzi crp-10 protein.
independent continuant;pscar dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pscar . cmv promotor is used.
independent continuant;lnp-ncov sarna-02;a sars-cov-2 self-amplifying rna vaccine sponsored by mrc/uvri and lshtm uganda research unit
independent continuant;rvv-sars vaccine;a mers dna vaccine made of plasmid vaccines that encoded s1 subunit only
independent continuant;moraten vaccine;a more attenuated measles vaccine that targets measles virus strain moraten.
independent continuant;improvac;improvac is a vaccine that stimulates the pig s own immune system to produce specific antibodies against gnrf. this temporarily inhibits testes function and thus stops the production and accumulation of boar taint-causing compounds.
independent continuant;vaccine component;a processed material that is output of the vaccine preparation and part of a vaccine.
independent continuant;tween 20 vaccine stabilizer;a polysorbate 20 vaccine stabilizer that is tween 20. 
independent continuant;dda vaccine adjuvant;a synthetic vaccine adjuvant that is dimethyldioctadecylammonium bromide (dda), a lipophilic quaternary ammonium salt known as a good adjuvant when co-administered systemically or nasally with an antigen.
independent continuant;pvac1 3.0 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pvac1 3.0. the manufacturer is invitrogen.
independent continuant;parasite vaccine vector;a vaccine vector that uses a parasite as the vector.
independent continuant;canine distemper virus vaccine;a vaccine that protects against canine distemper virus.
independent continuant;adenovirus serotype 5 vaccine vector;an adenovirus vaccine vector that uses an adenovirus serotype 5 strain.
independent continuant;pvcl1012 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pvcl1012. the promoter is hcmv and the manufacturer is vical inc.
independent continuant;bovine parainfluenza 3 virus vaccine;viral vaccine that is used to protect against bovine parainfluenza 3 virus (bpiv-3) (bovine parainfluenza virus 3) infection
independent continuant;cocktail vaccine;a vaccine that contains two or more individual vaccines. 
independent continuant;m-m-r ii;a measles-mumps-rubella vaccine that is live attenuated and manufactured by merck & co, inc. 
independent continuant;spirochaetes vaccine;a vaccine that is used against an infection by a pathogen under spirochaetes.
independent continuant;rubivirus vaccine;a vaccine that is used against an infection by a pathogen under rubivirus.
independent continuant;ag0302-covid19;a sars-cov-2 dna vaccine developed by anges.
independent continuant;rbd-hbsag vlp;a sars-cov-2 virus-like particle vaccine that contains the receptor binding domain (rbd) of the sars-cov-2 spike (s) protein and is adjuvanted with aluminum.
independent continuant;horse encephalomyelitis-influenza-west nile virus vaccine;a horse vaccine that protects against eee, vee, wee, influenza virius infection, and west nile virus infection. 
independent continuant;tri-immunol;this vaccine is given to provide protection against diphtheria, tetanus, and pertussis in children between 6 weeks and 7 years old.
independent continuant;as03 vaccine adjuvant;as03 is an emusion vaccine adjuvant that contains -tocopherol and squalene, two biodegradable polyprenyls, in an oil-in-water emulsion.
independent continuant;recombinant heterologous vector vaccine;a recombinant vector vaccine that uses a homologous vector, i.e., when the target species of the vaccine is not one of the natural hosts for the vector.
independent continuant;doco-pro-rbd-1 + mf59;a sars-cov-2 protein subunit vaccine manufactured by the university of melbourne.
independent continuant;usa licensed human vaccine;a licensed human vaccine that is licensed in the usa.
independent continuant;adcld-cov19;a sars-cov-2 replication-defective human adenovirus type 5/35 vector based vaccine expressing the s protein.
independent continuant;pathogen organism component in vaccine;a vaccine component that originates from an organism such as a pathogen or a modified organism.
independent continuant;polysorbate 80 vaccine emulsifier;a vaccine emulsifier that uses polysorbate 80, also known as polyoxyethylene sorbitan monooleate or tween 80.
independent continuant;hexavax;a hexavalent vaccine that has been withrawn on june 2012 by the european commission
independent continuant;irradiation-inactivated vaccine;an inactivation vaccine that is prepared by irradiation inactivation.
independent continuant;live attenuated brucella abortus vaccine;live attenuated brucella vaccine is a live attenuated vaccine that protects against a brucella abortus infection.
independent continuant;chitosan vaccine adjuvant;aminoglycan consisting of -(1 4)-linked d-glucosamine residues
independent continuant;dmlt vaccine adjuvant;double mutant of heat-labile e. coli toxin (lt) at r192g/l211a or lt(r192g/l211a)
independent continuant;bovine coronavirus vaccine;viral vaccine that is used to protect against bovine coronavirus infection
independent continuant;aeromonas hydrophila gene;a bacterial gene that is from aeromonas hydrophila.
independent continuant;bbibp-corv;a sars-cov-2 inactivated whole virus vaccine that produced in vero cells that is developed by the beijing institute of biological products.
independent continuant;smallpox virus vaccine;a viral vaccine that protects against infection with smallpox virus.
independent continuant;pcmvi(-h3)ubs dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmvi(-h3)ubs. this plasmid contains a cmv promoter.
independent continuant;sclavo peptide vaccine adjuvant;a cytokine vaccine adjuvant that contains the 163-171 peptide of il-1 .
independent continuant;meningococcal conjugate and haemophilis b vaccine;an active immunizing combination agent that is used to prevent infection caused by certain groups of meningococcal bacteria and haemophilus influenza type b (hib) bacteria.
independent continuant;bordetella pertussis gene;a bacterial gene that is from bordetella pertussis.
independent continuant;carnivora vaccine;vaccine that used for immunizing carnivora.
independent continuant;y. pestis f1 protein vaccine;a yersinia pestis subunit vaccine that uses y. pestis f1 protein as antigen.
independent continuant;killed corynebacterium parvum vaccine adjuvant;a microbial derivative vaccine adjuvant derived from heat-killed corynebacterium parvum.
independent continuant;qazcovac-p;a sars-cov-2 protein subunit vaccine manufactured by the research institute for biological safety problems in kazakhstan
independent continuant;comirnaty;a sars-cov-2 rna vaccine formed from a lipid nanoparticle-formulated trimerized sars-cov-2 receptor-binding domain
independent continuant;haemophilus influenzae serotype b vaccine;a vaccine that protects against haemophilus influenzae type b infection.
independent continuant;salmonella-ctla4-s sars dna vaccine;'a sars dna vaccine that is made from oral live-attenuated auxotrophic s. typhimurium aroa strain sl7207 that contained ctla4hingesars800 with sars-cov s protein 
independent continuant;tdap;a vaccine that protects adolescents and adults from tetanus, diphtheria, and pertussis.
independent continuant;pegfp-n1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pegfp-n1. this plasmid is 4733 base pairs in length and contains a cmv promoter and kanamycin resistance gene.
independent continuant;live attenuated avian reovirus vaccine;an avian reovirus vaccine that using live attenauted reovirus. 
independent continuant;vesicular stomatitis virus vaccine vector;a viral vaccine vector that uses a vesicular stomatitis virus (vsv) as the vector.
independent continuant;formaldehyde vaccine preservative;a vaccine preservative that contains formaldehyde.
independent continuant;pam3cys vaccine adjuvant;three palmitic acid groups that are bound in an ester and amide linkage to a cysteine residue.
independent continuant;lyophilized vaccine powder;a vaccine powder that is freeze-dried and lyophilized. 
independent continuant;vaccinia virus vaccine;a smallpox virus vaccine that uses vaccinia virus
independent continuant;yf-17dd vaccine;a yellow fever virus vaccine that uses the live attenated 17dd strain.
independent continuant;interleukin-7 vaccine adjuvant;a cytokine vaccine adjuvant that includes il-7.
independent continuant;leishmania tarentolae vaccine vector;a parasite vaccine vector using a live attenuated leishmania tarentolae strain. 
independent continuant;allergy vaccine;a vaccine that targets for allergy.
independent continuant;vaccine powder;a vaccine component that contains the solid form of all vaccine components. a vaccine can be reconstituted by mixing vaccine powder with vaccine solvent.
independent continuant;qs-21 vaccine adjuvant;a tensoactive compound vaccine adjuvant that is composed of extracts from the bark of the quillaja saponaria molina tree. specifically, it is an acylated 3, 28-bisdesmodic triterpene glycosides (1,3) or saponin with a molecular formula of c92o46h148 and molecular weight of 1990 da. qs-21 is one of the active fractions of the bark of chilean tree, quillaja saponaria, purified using a reverse-phase chromatography (rp-hplc).
independent continuant;enterovirus vaccine;a vaccine that is used against an infection by a pathogen under enterovirus.
independent continuant;feline herpesvirus 1 vaccine;viral vaccine that is used to protect against feline herpesvirus 1 (felid herpesvirus 1) infection
independent continuant;mrna-1073;a sars-cov-2 mrna vaccine by moderna that combines the mrna-1273 covid-19 vaccine and the mrna-1010 influenza vaccine.
independent continuant;fakhravac;a sars-cov-2 inactivated vaccine developed by organization of defensive innovation and research in iran
independent continuant;rabivac;a human diploid cell vaccine against rabies, a viral infectious disease.
independent continuant;measles virus vaccine foreign to usa;a measles virus vaccine manufactured outside of the u.s.
independent continuant;bupivacaine vaccine adjuvant;a synthetic vaccine adjuvant that is a local anaesthetic drug belonging to the amino amide group, and is used as a vaccine adjuvant in dna vaccines.
independent continuant;cholera toxin a1-subunit-proteina d-fragment fusion protein;a microbial derivative vaccine adjuvant composed of the cta1-dd fusion protein.
independent continuant;fluvax;for the prevention of influenza caused by influenza virus, types a and b. for the southern hemisphere 2017 season, the vaccine is indicated for use only in persons aged 5 years and over.
independent continuant;inactivated viral vaccine;a viral vaccine that is inactivated
independent continuant;trypanosoma brucei vaccine;a vaccine that protects against trypanosoma brucei.
independent continuant;pcdna1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna1. this plasmid is 4000 base pairs in length and contains a cmv promoter.
independent continuant;iss 1018 cpg odn vaccine adjuvant;a cpg dna vaccine adjuvant that is a short, synthetic, unmethylated cpg oligodeoxynucleotide (cpg odn) with immunostimulatory activity.
independent continuant;canarypox vaccine vector;an avipox virus vaccine vector that uses an attenuated canarypox virus strain
independent continuant;mrna-1273.214;a sars-cov-2 bivalent mrna vaccine by moderna that contains the mrna-1273 covid-19 vaccine and the mrna-1273.214 omicron booster
independent continuant;as02 vaccine adjuvant;a combination vaccine adjuvant comprised of monophosphoryl lipid a (mpl), qs21 and an oil in water emulsion.
independent continuant;equine rotavirus vaccine;viral vaccine that is used to protect against equine rotavirus infection
independent continuant;sorbitol vaccine stabilizer;a vaccine stabilizer that is specifically made by sorbitol.
independent continuant;heat-killed vaccine;an inactivation vaccine that is prepared by heat inactivation.
independent continuant;acel-imune;a dtap vaccine used to keep up protection (immunity) against diphtheria, tetanus (lockjaw) and pertussis (whooping cough) in children and adults who have been vaccinated for these diseases in the past.
independent continuant;v1r dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label v1r.
independent continuant;mycobacterium avium gene;a bacterial gene that is from mycobacterium avium.
independent continuant;aluminum potassium sulfate adjuvant;an aluminum vaccine adjuvant that is aluminum potassium sulfate (alk(so4)2).
independent continuant;chimpanzee adenovirus oxford1 vaccine vector;a chimpanzee adenovirus vaccine vector that patented by oxford and derived from chad serotype y25 that exchanges the native e4 orf4, orf6 and orf6/7 genes for those from hadv-c5
independent continuant;lyme disease vaccine;a vaccine that prevents lyme disease caused by borrelia burgdorferi.
independent continuant;pci30 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pci30. this plasmid contains a cmv promoter, ampicillin resistance gene, t7 rna polymerase promoter, a multiple cloning region and a 6xhis tag coding sequence.
independent continuant;vaccine injection site;a vaccination site that is used for injection of a vaccine. 
independent continuant;hib-imune;kallan roan, oliver he
independent continuant;equid herpesvirus gene;a viral gene that is from equid herpesvirus 1.
independent continuant;intravenous route;route of administration that is located in the vein
independent continuant;pcn3 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcn3. the plasmid promoter is cmv.
independent continuant;trypanosoma cruzi vaccine;a vaccine that protects against trypanosoma cruzi.
independent continuant;bactrl-spike;a sars-cov-2 oral dna vaccine that delivers plasmids containing synthetic dna encoding spike protein from sars-cov-2.
independent continuant;adenoviral vector ad5 expressing siv gag protein;a recombinant adenovirus (ad5) expressing the codon-optimized siv gag gene. pmid: 11797011.
independent continuant;porcine parvovirus vaccine;viral vaccine that is used to protect against porcine parvovirus infection
independent continuant;ag0301-covid19;a sars-cov-2 dna vaccine developed by anges.
independent continuant;avian reovirus vaccine;viral vaccine that is used to protect against avian reovirus (avian orthoreovirus) infection
independent continuant;pvf dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pvf.
independent continuant;simian adenovirus chad63 vaccine vector;an adenovirus vaccine vector that uses the simian adenovirus chad63 strain.
independent continuant;pcaggs/mcs dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcaggs/mcs. this plasmid has a chicken beta-actin promoter, contains a multiple cloning site between the ecori and bglii sites of the rabbit beta-globin gene, and has restriction sites for the enzymes saci, clai, nsii, asp718, smai, sphi, xhoi, and nhei.
independent continuant;baculovirus vaccine vector;a viral vaccine vector that uses a baculovirus as the vector 
independent continuant;lymphocytic choriomeningitis mammarenavirus vaccine;a viral vaccine that protects against infection with lymphocytic choriomeningitis mammarenavirus
independent continuant;hepatitis b virus vaccine;a viral vaccine that protects against infection with hepatitis b virus.
independent continuant;bovine papillomavirus vaccine;viral vaccine that is used to protect against bovine papillomavirus infection
independent continuant;arct-154;a sars-cov-2 rna vaccine by arcturus therapeutics, inc.
independent continuant;pcat dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcat. this plasmid is 4364 base pairs in length and contains an ampicillin resistance gene.
independent continuant;t. cruzi vaccine using attenuated salmonella expressing t. cruzi cruzipain;a t. cruzi vaccine that uses attenuated salmonella to express t. cruzi cruzipain protein.
independent continuant;plasmodium berghei vaccine;a malaria vaccine that protects against malaria caused by plasmodium berghei.
independent continuant;mrna-1283;a sars-cov-2 refrigerator-stable mrna vaccine by moderna that encodes for the portions of the sars-cov-2 spike protein critical for neutralization, specifically the receptor binding domain (rbd) and n-terminal domain (ntd)
independent continuant;edible vaccine;a vaccine that is edible and derived from an edible plant. the transgenic plant is used as recombinant protein production system. the edible plant tissue functions as an oral vaccine.
independent continuant;pwrg7079 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pwrg7079. this plasmid contains a cmv promoter and a kanamycin resistance gene and differs from pwrg7077 by the insertion of a tpa sequence.
independent continuant;pcmv-tpa/zs7 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcmv-tpa/zs7. this plasmid contains a cmv promoter and is generated from pcmv-zs7 by attaching htpa to ospc zs7.
independent continuant;herpes simplex virus vaccine 1 vector;a herpes simplex virus vaccine vector that uses a virus type 1 strain 
independent continuant;acetone-dried typhoid vi polysaccharide vaccine;a polysaccharide vaccine to prevent typhoid caused salmonella typhi. acetone is used to inactivate culture, and dried.
independent continuant;hendra virus vaccine;a vaccine that protects against hendra virus.
independent continuant;pngvl4a dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pngvl4a. this plasmid has a cmv promoter and kanamycin and ampicillin resistance genes.
independent continuant;sars-cov pci-n dna vaccine;a plasmid pci-n, encoding the full-length n gene of sars-cov, was constructed and expressed in escherichia coli dh5alpha
independent continuant;pctpa dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pctpa. this plasmid is based on pcdna3 and contains the htpa signal sequence.
independent continuant;yellow fever virus vaccine;a viral vaccine that protects against infection with yellow fever virus.
independent continuant;marker vaccine;a vaccine that is used in conjunction with diagnostic tests to differentiate vaccinated animals from carrier animals. it can be a subunit or a gene-deleted vaccine.
independent continuant;ub-612;a sars-cov-2 s1-rbd-protein based vaccine developed by vaxxinity
independent continuant;vaccine preservative;vaccine preservative is an vaccine additive that is added to a vaccine formulation to prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during use. ref: finn tm and egan w, in vaccines fifth edition, 2008. page 73.
independent continuant;reticuloendotheliosis virus vaccine;a viral vaccine that protects against infection with reticuloendotheliosis virus
independent continuant;diphtheria toxoid vaccine;a diphtheria vaccine that uses diphtheria toxoid
independent continuant;cell culture residual in vaccine;a vaccine residual that is generatead from cell culture for vaccine preparation. examples include: antibiotics, sensitizing substances, bacterial and cellular residuals, and adventitious agents.
independent continuant;shigella vaccine;a bacterial vaccine that protects against infections with shigella species.
independent continuant;covid-evax;a sars-cov-2 plasmid dna vaccine manufactured by takis and rottapharm biotech
independent continuant;mvvac2-mers-s(h) vaccine;a mers recombinant vector vaccine made of live-attenuated measles virus (mv) vaccine encoding the mers-cov spike protein (mers-s).
independent continuant;edwardsiella tarda eib202 vaccine vector;a bacterial vaccine vector using a live attenuated edwardsiella tarda strain eib202
independent continuant;orthopoxvirus vaccine vector;a poxvirus vaccine vector that uses an orthopox virus as the vector
independent continuant;intramuscular route;a route of administration that inject the material(such as vaccines, allergens) directly into a muscle.
independent continuant;vsa-3 vaccine adjuvant;vsa-3 is an emulsion vaccine adjuvant which is an emulsion plus dda.
independent continuant;hepatyrix;a vaccine which helps prevent hepatitis a and typhoid fever. this vaccine should only be given to adults and teenagers aged 15 years and above.
independent continuant;corynebacterium pseudotuberculosis vaccine;a diphtheria vaccine against infection with corynebacterium pseudotuberculosis
independent continuant;psca1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label psca1.
independent continuant;oka varicella vaccine vector;a poxvirus vaccine vector that uses an attenuated oka varicella virus strain
independent continuant;protein vaccine stabilizer;a vaccine stabilizer that is a protein.
independent continuant;omnihib;a haemophilus influenzae type b conjugate vaccine manufactured by gsb.
independent continuant;rvsv-ebov;an ebola virus vaccine that uses a recombinant vesicular stomatitis virus (rvsv) vector expressing an ebola filovirus glycoprotein
independent continuant;avipox virus vaccine vector;a poxvirus vaccine vector that uses an avipox virus as the vector
independent continuant;schistosoma japonicum vaccine;a protozoan vaccine that protects against infection with schistosoma japonicum
independent continuant;c. posadasii subunit pmp1 protein vaccine;a coccidioides vaccine that contains c. posadasii pmp1 protein
independent continuant;tiv dresden;a trivalent influenza vaccine contianing two a influenza strains and one b influenza strain.
independent continuant;vxs-1223;a sars-cov-2 protein subunit vaccine manufactured by vaxxas pty ltd
independent continuant;'human herpesvirus 2 gene';a viral gene that is from human herpesvirus 2.
independent continuant;h1n1 influenza vaccine;h1n1 influenza vaccine is an influenza virus vaccine that is used to vaccinate against h1n1 influenza subtype vaccine.
independent continuant;turkey hemorrhagic enteritis virus vaccine;viral vaccine that is used to protect against turkey hemorrhagic enteritis virus (turkey adenoirus 3) infection
independent continuant;measles-mumps-rubella vaccine;a measles-mumps vaccine that also protects against infection with rubella virus.
independent continuant;mycoplasma synoviae vaccine;a bacterial vaccine against mycoplasma synoviae infection
independent continuant;immunized organism;an organism that is immunized for a disease
independent continuant;had5-covid-19;a sars-cov-2 human adenovirus serotype 5 (had5) vector vaccine with e1/e2b/e3 deletions expressing sars-cov-2 viral antigen spike fusion protein and nucleocapsid with an enhanced t-cell stimulation domain.
independent continuant;ovastim;a vaccine used to increase the fecundity in breeding ewes. ovastim increases the number of multiple ovulations and therefore the number of multiple births.
independent continuant;western equine encephalomyelitis virus gene;a viral gene that is from western equine encephalomyelitis virus.
independent continuant;almansour-001;a sars-cov-2 dna vaccine developed by imam abdulrahman bin faisal university.
independent continuant;francisella tularensis vaccine;a bacterial vaccine against an infection with f. tularensis.
independent continuant;vibrio cholerae vaccine;a bacterial vaccine that prevents infection with vibrio cholera.
independent continuant;classical swine fever virus gene;a viral gene that is from classical swine fever virus.
independent continuant;avian pneumovirus vaccine;viral vaccine that is used to protect against avian pneumovirus (avian metapneumovirus) infection
independent continuant;revaxis;revaxis is a diphtheria, tetanus and poliomyelitis (inactivated) vaccine manufactured by sanofi pasteur. this vaccine helps boost protection against diphtheria, tetanus and poliomyelitis (polio).
independent continuant;sars-cov baculovirus s protein vaccine;a sars-cov recombinant vector made from a baculovirus vector expressing sars-cov s protein.
independent continuant;diphtheria-tetanus-pertussis-poliovirus-act-hib vaccine;a vaccine that protects against, diphtheria, tetanus, pertussis (whooping cough), polio, and haemophilus influenzae type b.
independent continuant;polyvalent pneumococcal vaccine;a pneumococcal vaccine that is formed using polyvalent polysaccharides
independent continuant;marburg virus vaccine;a vaccine that protects against marburg virus.
independent continuant;prime-2-cov-beta;a sars-cov-2 protein subunit vaccine manufactured by speransa therapeutics.
independent continuant;mycoplasma hyopneumoniae vaccine;bacterial vaccine that protect against mycoplasma hyopneumoniae infection
independent continuant;cv9201;a non-small cell lung cancer mrna-derived vaccine that contains modified mrnas encoding cancer-testis antigen ny-eso-1, melanoma-associated antigens c1 (mage-c1/ct7) and c2 (mage-c2/ct10), survivin, and the oncofetal antigen 5t4 with potential antitumor and immunomodulatory activities.
independent continuant;rotavirus vaccine;a viral vaccine that protects against infection with rotavirus.
independent continuant;listeria monocytogenes vaccine;a vaccine that protects against listeria monocytogenes.
independent continuant;coronavirus vaccine;a vaccine against coronavirus infection
independent continuant;menhibrix;a vaccine for active immunization to prevent invasive disease caused by neisseria meningitidis serogroups c and y and haemophilus influenzae type b. menhibrix is approved for use in children 6 weeks of age through 18 months of age. 
independent continuant;varicella-zoster virus vaccine;a herpesvirus vaccine that is used against varicella-zoster virus infection.
independent continuant;flavobacterium columnare vaccine;bacterial vaccine that is used to protect against flavobacterium columnare infection
independent continuant;noora;a sars-cov-2 subunit vaccine by bagheiat-allah university of medical sciences
independent continuant;pseudomonas aeruginosa vaccine;bacterial vaccine that is used to protect against pseudomonas aeruginosa infection
independent continuant;vrc-srsdna015-00-vp vaccine;a sars dna vaccine made of a single closed plasmid dna marcromolecule (vrc-8138) that produces a deletion mutant of the sars spike glycoprotein
independent continuant;inactivated poliomyelitis vaccine - ipv;a poliovirus vaccine that uses poliovirus particles that have been grown under controlled conditions and then killed to prevent disease caused from the vaccine.
independent continuant;leishmania donovani gene;a protozoan gene that is from leishmania donovani.
independent continuant;actinobacillus pleuropneumoniae vaccine;a bacterial vaccine against a. pleuropneumoniae infection
independent continuant;campylobacter vaccine;a vaccine that protects against campylobacter bacterial infectioni.
independent continuant;ppjv7563 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label ppjv7563. this plasmid has a human cytomegalovirus immediate early promoter.
independent continuant;vee virus vaccine;viral vaccine that is used to protect against vee virus (venezuelan equine encephalitis virus) infection
independent continuant;simian immunodeficiency virus gene;a viral gene that is from simian immunodeficiency virus.
independent continuant;tice bcg;tice bcg for intravesical use, is an attenuated, live culture preparation of the bacillus of calmette and guerin (bcg) strain of mycobacterium bovis.
independent continuant;calcium phosphate vaccine adjuvant;a mineral salt vaccine adjuvant composed of calcium phosphate.
independent continuant;sii b.1.617.2;a sars-cov-2 monovalent protein subunit vaccine by novavax immunizing against the b.1.617.2 (delta) variant and containing the matrix-m1 adjuvant
independent continuant;mumps-rubella vaccine foreign to usa;a mumps-rubella vaccine manufactured outside of the u.s.
independent continuant;lactobacillus gasseri vaccine vector;a bacterial vaccine vector that uses an attenuated lactobacillus gasseri strain
independent continuant;sedoreovirinae vaccine;a vaccine that is used against an infection by a pathogen under sedoreovirinae.
independent continuant;vr1040 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label vr1040. this plasmid contains four copies of the mouse immunostimulatory sequence and is similar to vr1012.
independent continuant;plasmodium berghei gene;a plasmodium gene that is from plasmodium berghei.
independent continuant;covidity;a sars-cov-2 dna vaccine developed by scancell ltd.
independent continuant;mannheimia haemolytica gene;a bacterial gene that is from mannheimia haemolytica.
independent continuant;mf59 vaccine adjuvant;pmid: 20488726
independent continuant;duck hepatitis virus 1 vaccine;viral vaccine that is used to protect against duck hepatitis virus 1 (duck hepatitis a virus) infection
independent continuant;live attenuated viral vaccine;a viral vaccine that is live attenuated
independent continuant;b. melitensis rev. 1 with bp26 and omp31 deletions;b. melitensis bp26 and omp31 deletion vaccine is a brucella melitensis vaccine that has double deletions of bp26 and omp31.
independent continuant;recombinant hifn-gamma/interferon-g vaccine adjuvant;an ifn-gamma vaccine adjuvant that is composed of recombinant hifn-gamma.
independent continuant;bovine respiratory syncytial virus vaccine;viral vaccine that is used to protect against bovine respiratory syncytial virus infection
independent continuant;vrp expressing vp24;an ebola virus vaccine that is composed of vee replicon particle (vrp) encoding ebola virus vp24 protein.
independent continuant;neisseria meningitidis vaccine;a bacterial vaccine that prevents neisseria meningitidis infection.
independent continuant;intraperitoneal route;a route of administration that located in the peritoneum.
independent continuant;syntex adjuvant formulation;a muramyl dipeptide derivative (threonyl-mdp) in an oil-in-water (o/w) emulsion vehicle.
independent continuant;fowlpox virus vaccine vector;an avipox virus vaccine vector that uses a fowlpox virus as the vector
independent continuant;mycobacterium vaccine;a bacterial vaccine that protects against mycobacterium bacterial infection.
independent continuant;pcdna3.1/hygro(-) dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pcdna3.1/hygro(-). this plasmid is 5596 base pairs in length and contains a cmv promoter and an ampicillin resistance gene.
independent continuant;kkf24;kkf24 is a recombinant strain of francisella novicida u112 with iglc mutation (f. novicida delta-iglc::ermc). pmid: 14680699.
independent continuant;hepatovirus vaccine;a vaccine that is used against an infection by a pathogen under hepatovirus.
independent continuant;lta1 vaccine adjuvant;lta1 is a vaccine adjuvant made from the a subunit of heat-labile (lt) enterotoxin of enterotoxigenic escherichia coli (etec). this lta1 adjuvant is able to induce th1, th2, and th17 immune responses.
independent continuant;gh1-qbeta vaccine;the gh1-qbeta vaccine is a novel pandemic-influenza vaccine produced by covalently linking the globular head domain of haemagglutinin (gh1) from a/california/07/09 produced in e. coli to vlps from the bacteriophage qbeta
independent continuant;ad41.mers vaccine;a mers recombinant vector made of adenovirus type 41 used as vector for mers-cov s protein. 
independent continuant;pgp.lamp-1 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pgp.lamp-1. this plasmid has a cmv promoter and contains the human lysosomal-associated membrane protein-1 signal sequence.
independent continuant;nbp2001;a sars-cov-2 protein subunit vaccine by sk bioscience
independent continuant;recombinant e. coli mutant vaccine;an e. coli vaccine that uses a live mutant by knocking out one gene(s) from a wild type e. coli.
independent continuant;baiya sars-cov-2 vax 1;a sars-cov-2 subunit vaccine by baiya phytopharm co., ltd.
independent continuant;human immunodeficiency virus vaccine;a viral vaccine that protects against infection with human immunodeficiency virus that causes aids.
independent continuant;c. immitis subunit ure protein vaccine;a coccidioides vaccine that contains c. immitis subunit ure protein
independent continuant;lipid nanoparticle vector;a nanoparticle vector composed of lipids.
independent continuant;bbv154;a sars-cov-2 recombinant adenoviral vector vaccine that is manufactured by bharat biotech international ltd. and administered intranasally
independent continuant;bovine serum albumin vaccine additive;a protein vaccine stablizer that is specifically bovine serum albumin. 
independent continuant;diphtheria-tetanus-pertussis-poliovirus vaccine;a vaccine that protects against diphtheria, tetanus, pertussis, and poliovirus.
independent continuant;birds vaccine;vaccine that used for immunizing birds.
independent continuant;chlamydia trachomatis vaccine;a chlamydia bacterial vaccine against chlamydia trachomatis infection
independent continuant;vaccinee priority group;a population group that have priority for vaccination when a vaccine is first available.
independent continuant;adjumer vaccine adjuvant;a synthetic vaccine adjuvant that is pcpp salt.
independent continuant;h1n1 influenza monovalent vaccine;a monovalent vaccine used to protect against h1n1 influenza virus.
independent continuant;mpl + tdm vaccine adjuvant;monophosphoryl lipid a (detoxified endotoxin) from s. minnesota (mpl) and synthetic trehalose dicorynomycolate (tdm) in 2% oil (squalene)-tween 80-water.
independent continuant;japanese encephalitis virus vaccine;a viral vaccine that protects against infection with japanese encephalitis virus.
independent continuant;marek's disease virus vaccine;a vaccine that protects against marek's. disease virus.
independent continuant;neomycin residual;an antibiotics vaccine residual that has the antibiotics of neomycin. 
independent continuant;alkest tw 20 vaccine stabilizer;a polysorbate 20 vaccine stabilizer that is alkest tw20. 
independent continuant;chlamydia vaccine;a vaccine that protects against chlamydia bacterial infection.
independent continuant;covi-vac;a sars-cov-2 live, attenuated vaccine manufactured by codagenix, inc.
independent continuant;vaccine foreign to usa;this term was used by the usa vaers system to indicate the source, which is foreign to usa here, of the vaccine.
independent continuant;lv-smenp-dc;a sars-cov-2 recombinant vector vaccine by shenzhen geno-immune medical institute
independent continuant;hirame rhabdovirus vaccine;a viral vaccine that protects against infection with hirame rhabdovirus
independent continuant;multivalent vaccine;a vaccine that is designed to immunize against two or more strains of the same microorganism, or against two or more microorganisms.
independent continuant;f. tularensis vaccine lvs;a live attenuated francisella tularensis vaccine. it is available in american type culture collection with atcc id: 29684.
independent continuant;complex adenovirus vaccine vector;an adenovirus vaccine vector that uses a complex adenovirus as the vector strain.
independent continuant;human vaccinee population;a population of human beings who are vaccinated.
independent continuant;optaflu;a vaccine against flu (influenza) in adults, especially in those who run an increased risk of experiencing associated complications in case they fall ill with flu.
independent continuant;prc/cmv-hbs(s) dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label prc/cmv-hbs(s). this plasmid is 5618 base pairs in length and contains a cmv promoter and ampicillin resistance gene.
independent continuant;rsars-cov- e vaccine;a sars recombinant vector vaccine made from a line attenuated and recombinant sars-cov lacking the e gene
independent continuant;route of administration;a path that is located in gross anatomical part of an organism (e.g., human) and is used for administering a vaccine, a drug, fluid, poison, or other substance into the body. 
independent continuant;mv-014-212;a sars-cov-2 live, attenuated vaccine manufactured by meissa vaccines, inc. that expresses the spike (s) protein of sars-cov-2.
independent continuant;corynebacterium-derived p40 vaccine adjuvant;a microbial derivative vaccine adjuvant that is the p40 particulate fraction isolated from corynebacterium.
independent continuant;veterinary vaccine;veterinary vaccine is a vaccine that is used for animals (excluding humans), for example, pet, domestic, wildlife, and livestock animals.
independent continuant;west nile virus gene;a viral gene that is from west nile virus.
independent continuant;np-vrp;an ebola virus vaccine that is composed of vee replicon particle (vrp) encoding ebola virus np protein.
independent continuant;lassa fever virus vaccine;a vaccine that protects against lassa fever virus.
independent continuant;human serum cell culture residual in vaccine;a cell culture residual in vaccine that is human serum.
independent continuant;resiquimod vaccine adjuvant;a synthetic vaccine adjuvant, resiquimod is a chemical analog of imiquimod.
independent continuant;recombinant viral vector vaccine;a recombiant vector vaccine that is has a viral vector.
independent continuant;delns1-2019-ncov-rbd-opt1;an influenza virus vector sars-cov-2 vaccine administered as an intranasal spray manufactured by university of hong kong, xiamen university, and beijing wantai biological pharmacy.
independent continuant;corynebacterium diphtheriae vaccine;a bacterial vaccine that protects against infection with corynebacterium diphtheriae that causes diphtheria.
independent continuant;bacillus anthracis vaccine;a vaccine that protects against bacillus anthrax that causes anthrax.
independent continuant;bovine leukemia virus vaccine;a vaccine that protects against bovine leukemia virus.
independent continuant;borrelia burgdorferi gene;a bacterial gene that is from borrelia burgdorferi.
independent continuant;e. coli lt toxin derived vaccine adjuvant;a microbial derivative vaccine adjuvant that is derived from e. coli heat labile toxin lt.
independent continuant;viral hemorrhagic septicemia virus vaccine;a viral vaccine that protects against infection with viral hemorrhagic septicemia virus
independent continuant;gag-vrps;gag-vrps is a cocktail vaccine of v3014-packaged vrps expressing the sivsm h-4i nonmyristylated matrix-capsid region, full-length gp160, and a secreted form of gp160 (gp140). pmid: 12120997.
independent continuant;h. influenzae type b capsular polysaccharide vaccine;a vaccine used to prevent infection by haemophilus influenzae type b (hib) bacteria. the vaccine works by causing your body to produce its own protection (antibodies) against the disease.
independent continuant;lyssavirus vaccine;a vaccine that is used against an infection by a pathogen under lyssavirus.
independent continuant;african horse sickness virus vaccine;a viral vaccine that protects against infection with african horse sickness virus
independent continuant;melanoma vaccine;a cancer vaccine that is used against melanoma, a malignant tumor of melanocytes.
independent continuant;b. abortus l7/l12 fused to mbp;b. abortus l7/l12 fused to mbp is a b. abortus subunit vaccine using l7/l12 that uses recombinant l7/l12 fused on maltose binding protein mbp.
independent continuant;pasteurella multocida vaccine;bacterial vaccine that is used to protect against pasteurella multocida infection
independent continuant;human metapneumovirus vaccine;a viral vaccine that protects against infection of human metapneumovirus.
independent continuant;cvxga1;a sars-cov-2 recombinant vector vaccine manufactured by cyanvac llc
independent continuant;gelatin vaccine stabilizer;a vaccine stabilizer that is gelatin.
independent continuant;rna vaccine;a vaccine that uses rna(s) derived from a pathogen organism.
independent continuant;t. cruzi dna vaccine pgfp-tsa1;a t. cruzi dna vaccine that uses a dna plasmid pgfp expressing t. cruzi tsa-1 protein.
independent continuant;infectious pancreatic necrosis virus vaccine;a viral vaccine against infection of a lymphocytic choriomeningitis virus.
independent continuant;giardia duodenalis vaccine;protozoan vaccine that is used to protect against giardia intestinalis infection
independent continuant;haemophilus b and hepatitis b vaccine;a viral vaccine against hepatitis b virus and at the same time against bacterial h. influenzae serotype b.
independent continuant;protective vaccine antigen;the vaccine antiegn that induces protective immune response. 
independent continuant;covid-19 mrna vaccine by shanghai east hospital and stemirna therapeutics;a sars-cov-2 mrna vaccine by shanghai east hospital and stemirna therapeutics
independent continuant;mtp-pe liposomes vaccine adjuvant;mtp-pe liposomes are a liposome-based vaccine adjuvant that consists of liposomes containing the synthetic lipophilic analog of muramyl dipeptide, muramyl tripeptide phosphatidylethanolamine (mtp-pe).
independent continuant;saf-1 vaccine adjuvant;saf-1 is a combination vaccine adjuvant that is composed of threonyl-mdp (0.05-1%) in an emulsion vehicle [5% squalane, 2.5% pluronic l121, 0.2% polysorbate 80 and phosphate buffered saline (ph 7.4)].
independent continuant;helicobacter pylori vaccine;a vaccine that protects against helicobacter pylori.
independent continuant;v-01;a sars-cov-2 subunit vaccine developed by livzon mabpharm inc.
independent continuant;vaccinee population;a population group that are vaccinated with a specific vaccine
independent continuant;apl023 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label apl023.
independent continuant;coxsackievirus vaccine;a viral vaccine that protects against infection with coxsackievirus
independent continuant;sars-cov gene;a viral gene that is from sars-cov.
independent continuant;pumvc4b dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pumvc4b. this plasmid is 4478 base pairs in length and contains a cmv promoter and kanamycin and ampicillin resistance genes.
independent continuant;vbi-2902a;a sars-cov-2 virus-like particle vaccine that expresses a modified version of the sars-cov-2 spike (s) glycoprotein and is equipped with an aluminum phosphate adjuvant. it is manufactured by vbi vaccines inc. and is delivered intramuscularly.
independent continuant;diphtheria-tetanus-pertussis-poliovirus-haemophilus b vaccine;a vaccine that protects against, diphtheria, tetanus, pertussis (whooping cough), polio, and haemophilus influenzae type b.
independent continuant;foot-and-mouth disease virus vaccine;a viral vaccine that protects against infection with foot-and-mouth disease virus.
independent continuant;prc dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label prc. this plasmid is 7400 base pairs in length and contains cmv and rsv promoters.
independent continuant;fecundin;a fertility vaccine that enhance fertility in sheep.
independent continuant;live vaccine organism;a vaccine organism that is live
independent continuant;infanrix tetra;a combination vaccine against diphtheria, tetanus, acellular pertussis, and inactivated poliomyelitis for individuals ages from 16 months to 13 years of age.
independent continuant;ko ak-19 inaktif adjuvanl covid-19 vaccine;a sars-cov-2 inactivated virus vaccine by kocak farma
independent continuant;streptococcus equi vaccine;a bacterial vaccine against s. equi infection
independent continuant;cat vaccine;vaccine that used for immunizing cat (felis catus)
independent continuant;d-murapalmitine vaccine adjuvant;a synthetic adjuvant that is an mdp analog called d-murapalmitine.
independent continuant;live attenuated vaccine organism;a vaccine organism that is live and attenuated
independent continuant;f. tularensis vaccine fsc043;a spontaneous mutant of the schu s4 strain that protects against virulent f. tularensis infection. pmid: 16299332.
independent continuant;bcg vaccine ssi;pharmacotherapeutic group (atc code): j 07 an 01.
independent continuant;brucella ovis vaccine;a brucella vaccine against infection wtih b. ovis
independent continuant;toxoplasma gondii gene;a protozoan gene that is from toxoplasma gondii.
independent continuant;inactivated influenza vaccine;inactivated influenza vaccine is an inactivated viral vaccine that targets at influenza viral infections.
independent continuant;yersinia ev76;a yersinia pestis vaccine that is a pigmentation negative mutant of y. pestis derived from a fully virulent strain.
independent continuant;bacterium protein;a protein from a bacterium
independent continuant;pseudorabies virus gene;a viral gene that is from pseudorabies virus.
independent continuant;ad5.mers-s vaccine;a mers recombinant vector vaccine made of a recombinant adenoviral vector encoding the full-length mers-cov s protein (ad5.mers-s)
independent continuant;live attenuated influenza vaccine;live attenuated influenza vaccine is a live attenuated vaccine that protects against influenza viral infection.
independent continuant;t. cruzi vaccine using sendai virus vector expressing amastigote surface protein-2;a t. cruzi vaccine that uses sendai virus vector to express t. cruzi amastigote surface protein-2.
independent continuant;dna vaccine expressing multiple hiv epitopes;a hiv vaccine that is composed of a dna vaccine expressing conserved, multiple hiv epitopes. pmid: 16359234.
independent continuant;vee vaccine vector;a viral vaccine vector that uses a venezuelan equine encephalitis virus strain as the vaccine vector
independent continuant;nago vaccine adjuvant;a synthetic vaccine adjuvant that is composed of neuraminidase-galactose oxidase (nago) a mixture of mixture of the two enzymes-neuraminidase and galactose oxidase.
independent continuant;hepatitis a virus-typhoid vaccine foreign to usa;a vaccine to protect individuals against infections caused by hepatitis a virus and typhoid fever bacteria.
independent continuant;oxford astrazeneca covid-19 vaccine;a sars-cov2 recombinat vector vaccine made of a chimpanzee adenovirus-vectored vaccine expressing the sars-cov-2 spike protein
independent continuant;provax dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label provax. this plasmid contains a cmv promoter and a hcg- leader sequence.
independent continuant;vrp expressing vp35;an ebola virus vaccine that is composed of vee replicon particle (vrp) encoding ebola virus vp35 protein.
independent continuant;herpes simplex virus type 1 vaccine;a vaccine that protects against herpes simplex virus type 1 and 2.
independent continuant;human respiratory syncytial virus gene;a viral gene that is from human respiratory syncytial virus.
independent continuant;pak-4 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pak-4. this plasmid is 6600 base pairs in length and contains a cmv promoter and kanamycin and ampicillin resistance genes.
independent continuant;hiv based lentivirus vaccine vector;a lentivirus vaccine vector that uses a hiv strain as the vector
independent continuant;gemcovac-19;a sars-cov-2 mrna vaccine by gennova biopharmaceuticals limited
independent continuant;replicating adenovirus accine vector;an adenovirus vaccine vector that is able to replicate.
independent continuant;b. melitensis p39 recombinant protein vaccine;a brucella subunit vaccine that uses recombinant brucella melitensis 16m p39, a putative periplasmic binding protein. pmid: 11447155.
independent continuant;quadrivalent seasonal inactivated influenza vaccine 2014;quadrivalent seasonal inactivated influenza vaccine 2014 consisting of influenza a virus (a/california/7/2009(h1n1)), influenza a virus (a/texas/50/2012(h3n2)), influenza b virus (b/brisbane/60/2008), influenza b virus (b/massachusetts/02/2012)
independent continuant;protein subunit vaccine;a subunit vaccine that is made using a part of whole organism as subunit for vaccine development. 
independent continuant;exg-5003;a sars-cov-2 temperature-sensitive self-replicating rna vaccine expressing the receptor binding domain of the sars-cov-2 spike protein.
independent continuant;bovine parainfluenza virus vaccine vector;a viral vaccine vector that uses a bovine parainfluenza virus strain as vector
independent continuant;yersinia pseudotuberculosis gene;a bacterial gene that is from yersinia pseudotuberculosis.
independent continuant;pnd-14 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pnd-14. this plasmid contains a cmv promoter, ampicillin resistance gene, a tissue plasminogen activator leader sequence, a bovine growth hormone terminator, and constitutive transport element from simian retrovirus.
independent continuant;enterohemorrhagic e. coli vaccine;an e. coli vaccine against enterohemorrhagic e. coli infections
independent continuant;covac;a sars-cov-2 subunit vaccine with the s1 component of the sars-cov-2 spike (s) protein and swe adjuvant.
independent continuant;live attenuated feline panleukopenia virus vaccine;a feline panleukopenia virus vaccine where the virus used is live attenuated. 
independent continuant;orf virus vaccine vector;a poxvirus vaccine vector that uses an orf virus which is a parapoxvirus.
independent continuant;sars ndv-vf/s vaccine;a sars-cov recombinant vector vaccine that is made from the newcastle disease virus from the lentogenic lasota strain expressing sars-cov s protein.
independent continuant;ifn-gamma vaccine adjuvant;a cytokine vaccine adjuvant that includes ifn-gamma.
independent continuant;pumvc3 dna vaccine plasmid;a dna vaccine plasmid vector that has the plasmid label pumvc3. this plasmid is 4030 base pairs in length and contains a cmv promoter and kanamycin resistance gene.
independent continuant; -propiolactone-inactivated sars-cov vaccine;a sars inactivated vaccine made from whole killed (inactivated by beta-propiolactone) sars-cov
independent continuant;avridine vaccine adjuvant;a synthetic vaccine adjuvant that is n, n-dioctadecyl-n , n -bis( 2-hydroxyethyl) propanediamine (avridine).
independent continuant;b. melitensis bp26 deletion vaccine;a b. melitensis vaccine that is recombinant b. melitensis rev. 1 vaccine with the bp26 deletion. it has similar vaccine efficacy to rev. 1. its advantage compared to rev. 1 is that this feature of bp26 deletion promotes diagnosis. pmid: 17070627.
independent continuant;typhim vi;typhim vi, typhoid vi polysaccharide vaccine, for intramuscular use, is a sterile solution containing the cell surface vi polysaccharide extracted from salmonella enterica serovar typhi, s typhi ty2 strain.
independent continuant;bovine albumin cell culture residual in vaccine;a cell culture residual in vaccine that is bovine albumin.
independent continuant;western equine encephalomyelitis virus vaccine;a vaccine that protects against western equine encephalomyelitis virus.
independent continuant;antibiotics vaccine residual;a vaccine residual that is from antibiotics used during the manufacture process.
independent continuant;'p. falciparum fmp1/as02a;a recombinant e. coli-expressed protein based upon the apical membrane antigen-1 (ama-1) of the 3d7 clone formulated with the as02a adjuvant. pmid: 17442466.
independent continuant;live attenuated vaccine;a live vaccine that is made from microbes that have been attenuated (weakened) in the laboratory so that they can't cause disease.
independent continuant;horse encephalomyelitis eev, vev, and wev combination vaccine;a viral vaccine against horse eev, wev, and vee viral infections
independent continuant;amorphous aluminum hydroxyphosphate sulfate adjuvant;an aluminum vaccine adjuvant that is a a proprietary aluminum hydroxyphosphate sulfate formulation that is both physically and functionally distinct from traditional aluminum phosphate and aluminum hydroxide adjuvants.
independent continuant;b. melitensis rev. 1 with p39 deletion;a b. melitensis vaccine that is recombinant b. melitensis rev. 1 vaccine with the p39 gene deletion.
independent continuant;abisco-100 vaccine adjuvant;a tensoactive compound vaccine adjuvant that is made from highly purified saponins.
independent continuant;imp covac-1;a sars-cov-2 subunit vaccine developed by university hospital tuebingen
independent continuant;maraba virus vaccine vector;a viral vaccine vector that uses a maraba virus strain
independent continuant;gallid herpesvirus 1 vaccine;viral vaccine that is used to protect against gallid herpesvirus 1 infection
independent continuant;microencapsulated b. melitensis mutant vaccine;a b. melitensis vaccine that is composed of live brucella melitensis attenuated mutant delivered using a microsphere delivery system.
independent continuant;zf2001;a sars-cov-2 subunit vaccine composed of the sars-cov-2 s protein receptor-binding domain produced in chinese hamster ovary (cho) cells and adjuvant aluminum hydroxide.
independent continuant;bacterial vaccine;a vaccine that targets against a bacterial disease.
independent continuant;salmonella enteritidis gene;a bacterial gene that is from salmonella enteritidis.
independent continuant;intradermal route;a route of administration that inject the material(such as vaccines, allergens) into the skin itself.
independent continuant;nontypeable haemophilus influenzae;nontypeable haemophilus influenzae (nthi) is a nonencapsulated haemophilus influenzae (a gram-negative bacterium). it is the cause of a number of human respiratory tract diseases, such as otitis media, sinusitis, bronchitis, and pneumonia.
independent continuant;sc-ad6-1;a sars-cov-2 recombinant adenoviral vector vaccine by tetherex pharmaceutical corporation
independent continuant;dna vaccine plasmid vector;a vaccine component that is composed of a plasmid and used in the generation of a dna vaccine. 
independent continuant;saponin vaccine adjuvant;a tensoactive compound vaccine adjuvant that is derived from saponin, a compound that is an immunostimulator found in the plant p. senega.
independent continuant;raccoon poxvirus vaccine vector;an orthopoxvirus vaccine vector that uses an attenuated raccoon poxvirus strain
independent continuant;squalene vacccine adjuvant;an emulsion vaccine adjuvant that contains an organic polymer with some antigenic epitopes which might be shared with other organic polymers acting as immunostimulators.
independent continuant;omicron covid-19 inactivated vaccine by china national biotec group company limited;a sars-cov-2 inactivated vaccine developed by china national biotec group company limited
independent continuant;contraceptive vaccine;a vaccine that is used to prevent conception.
independent continuant;sucrose vaccine stabilizer;a vaccine stabilizer that is specifically made by a sucrose. 
independent continuant;mf59 vaccine adjuvant;an emulsion vaccine adjuvant consisting of an oil (squalene)-in-water nano emulsion.
independent continuant;human papillomavirus vaccine;a vaccine against human papillomavirus infection
independent continuant;cryptosporidium parvum vaccine;a vaccine that protects against cryptosporidium parvum.
independent continuant;orthohepadnavirus vaccine;a vaccine that is used against an infection by a pathogen under orthohepadnavirus.
independent continuant;ebola virus vaccine;a viral vaccine that protects against infection with ebola virus.
independent continuant;lyb001;a covid-19 virus-like particle vaccine developed by yantai patronus biotech co., ltd.
independent continuant;lipopolysaccharide vaccine adjuvant;a microbial derivative vaccine adjuvant made from bacterial lipopolysaccharide (lps) of gram-negative bacteria.
independent continuant;plant-based newcastle disease virus vaccine;the plant-based newcastle disease virus vaccine is a newcastle disease virus vaccine that is developed by dow agrosciences llc. it uses technology discovered at washington university. it is the first plant-made animal vaccine approved for sale in the united states.
independent continuant;nipah virus vaccine;a vaccine that protects against nipah virus.
independent continuant;inactivated whole mers-cov (iv) vaccine with cpg and alum;a mers inactivated whole virus vaccine that has a combined adjuvant that has a combined adjuvant of aluminum hydroxide and cpg oligodeoxynucleotides.
independent continuant;iscomatrix vaccine adjuvant;a particulate antigen delivery system that is a vaccine adjuvant comprising cholesterol, phospholipid and saponin but without antigen.
independent continuant;mutacol;a live attenuated v. cholerae vaccine that is manufactured by berna biotech, ltd. this vaccine uses the v. cholera strain cvd 103-hgr.
independent continuant;yersinia pav;a yersinia pestis subunit vaccine that contains staphylococcal protein a-v antigen fusion peptide (pav). pmid: 7622225.
independent continuant;rift valley fever virus vaccine;a vaccine that protects against rift valley fever virus.
independent continuant;autogenous poulty bacterin vaccine;an autogenous bacterin vaccine that is prepared for poultry use. 
specifically dependent continuant;protective antigen role;protective antigen is an antigen that stimulates protective immunity when used in vivo.
specifically dependent continuant;edible;a quality of edibility that inheres in a bearer by virtue of the bearer being suitable for oral ingestion as food, drug, or vaccine.
specifically dependent continuant;canada licensed human vaccine role;a canada licensed vaccine role that indicates the vaccine is used for human
specifically dependent continuant;vaccine organism inactivated;an organismal quality of a whole organism vaccine where the whole organism is inactivated/killed and lacks the capability of replication. 
specifically dependent continuant;unvaccinated;an organismal quality that indicates an organism (e.g., human) is unvaccinated with any vaccine.
specifically dependent continuant;nlrp3 receptor role;a role of a material entity that binds to nlrp3.
specifically dependent continuant;vaccine in research role;a vaccine role that is not licensed or in clinical trial. instead, it has been experimently approved to induce protection or treatment effect in vivo in at least an experimental animal model. 
specifically dependent continuant;unvaccinated with a licensed vaccine;a unvaccinated quality that indicates an organism has not been vaccinated with a licensed vaccine.
specifically dependent continuant;rna vaccine role;a vaccine role that indicates the vaccine being a rna vaccine. 
specifically dependent continuant;usa licensed vaccine role;a licensed vaccine role that indicates the vaccine occurs in usa.
specifically dependent continuant;tlr4 receptor role;a role of a material entity that binds to tlr4 and activates the receptor for pathogen recognition and activation of innate immunity.
specifically dependent continuant;vaccine preservative role;a role inhers in a vaccine component that when added into a vccine formmulation, it can prevent the growth of bacteria or fungi that inadvertently may be introduced into the vaccine during administrating process or the manufacturing process.
specifically dependent continuant;virus-like particle vaccine role;a vaccine role that inheres in a vaccine using virus-like particles (vlps), multiprotein structures that mimic the organization and conformation of authentic native viruses but lack the viral genome, potentially yielding safer and cheaper vaccines.
specifically dependent continuant;recombinant bacterial vector vaccine role;a recombinant vector vaccine role that inheres in a bacterium that carries a vaccine antigen for development of a particular vaccine 
specifically dependent continuant;vaccine organism virulent;a virulence of vaccine that shows a virulent pheontype of the organism as the major component of a vaccine. the virulent phenotype means that an vaccine organism is virulent and is able to cause a pathogenic phenotype in a host organism.
specifically dependent continuant;edibility;a physical quality inhering in a bearer by virtue of the bearer being fit to be eaten.
specifically dependent continuant;cell line repository role;a role that inheres in a cell line repository organization.
specifically dependent continuant;immunized by vaccination with a licensed vaccine;an organismal quality that indicates an organism (e.g., human) is immunized against a disease through vaccination with a licensed vaccine.
specifically dependent continuant;combination vaccine role;a vaccine role that indicates the vaccine being a combination vaccine. 
specifically dependent continuant;vaccine organism avirulent;a virulence of vaccine organism that shows an avirulent pheontype of the organism as the major component of a vaccine. the avirulence means that an vaccine organism is not virulent and does not cause pathogenic phenotype in a host organism.
specifically dependent continuant;vaccine efficacy;vaccine efficacy is an efficacy of a vaccine in induction of protective immune response in vivo or protection against infection of a virulent pathogen. specifically, vaccine efficacy (ve) is the percentage reduction in disease incidence attributable to vaccination, calculated by means of the following equation: ve(%) = (u - v)/u x 100 where u = the incidence in unvaccinated people and v = the incidence in vaccinated people. ref: hadler tc, et al. immunization in developing countries. in: vaccines. editors: plotkin s, et al. 2008. p1542-71.
specifically dependent continuant;vaccine emulsifier role;a role inheres in the vaccine component when it is added into vaccine's formulation, it tends to stabilizes an emulsion by increasing its kinetic stablity.
specifically dependent continuant;virmugen role;a role that is inherenced in a gene that can be mutated in a virulent pathogen, leading to an attenuated strain serving as a live attenuated vaccine strain.
specifically dependent continuant;vaccine strain role;a vaccine role that is borne by an organism strain serving as a vaccine
specifically dependent continuant;inedible;a quality of edibility that inheres in a bearer by virtue of the bearer being not suitable for oral ingestion.
specifically dependent continuant;vaccine protective antigen role;a vaccine antigen role that inheres in a vaccine antigen which is capable of inducing protective immunity. 
specifically dependent continuant;clinical trial vaccine role;a vaccine role that indicates a clinical trial status of a vaccine
specifically dependent continuant;vaccinated;an organismal quality that indicates an organism (e.g., human) is vaccinated with a vaccine.
specifically dependent continuant;tlr2 receptor role;a role of a material entity that binds to tlr2 and activates the receptor for pathogen recognition and activation of innate immunity.
specifically dependent continuant;protection efficacy;protection efficacy is an efficiency that is associated with protection by a biological product (e.g., vaccine) against a disease.
specifically dependent continuant;vaccine effectiveness;vaccine effectiveness is an effectiveness associated with a vaccine.
specifically dependent continuant;recombinant vector vaccine role;a vaccine role that indicates the vaccine being a recombinant vector vaccine. 
specifically dependent continuant;age at vaccination;age at vaccination is the age of an experiment animal at the time of vaccination.
specifically dependent continuant;dna vaccine role;a vaccine role that indicates the vaccine being a dna vaccine. 
specifically dependent continuant;conjugate vaccine role;a vaccine role that indicates the vaccine being a conjugate vaccine. 
specifically dependent continuant;licensed veterinary vaccine role;a licensed vaccine role that is bears in a licensed human vaccine.
specifically dependent continuant;vaccine organism viability;vaccine viability is a viability of a vaccine organism.
specifically dependent continuant;tlr3 receptor role;a role of a material entity that binds to tlr3 and activates the receptor for pathogen recognition and activation of innate immunity.
specifically dependent continuant;tlr8 receptor role;a role of a material entity that binds to tlr8 and activates the receptor for pathogen recognition and activation of innate immunity.
specifically dependent continuant;bacterial vaccine organism live attenuated;a live attenuated quality of a bacterial vaccine strain. 
specifically dependent continuant;therapeutic vaccine function;the therapeutic vaccine function is a function realized by the process of vaccination and leading to induction of an adaptive immune response to the antigens in a vaccine, which ameliorates a specific disorder.
specifically dependent continuant;vaccine host role;a role of host that contains vaccine. it is a role that inheres in an organism that is the target of a vaccine administration (vaccination process).
specifically dependent continuant;vaccine function;vaccine function is a function that inheres in a vaccine that induces protective immune response against a disease. it is realized in the immunization process in the host.
specifically dependent continuant;usa licensed human vaccine role;a usa licensed vaccine role that inheres ina vaccine approven to be by the us fda to be used for humans in the usa. 
specifically dependent continuant;animal model of vaccine research;animal model of vaccine research is a role played by some organism (e.g., mouse) that is used for vaccine research.
specifically dependent continuant;vaccine adjuvant role;an adjuvant role that inheres in a vaccine component which is added as part of a vaccine and induces enhanced adaptive immune response to the vaccine antigen. 
specifically dependent continuant;vaccine contraindication;a vaccine contraindication is a contraindication that increases the risks of a vaccination. 
specifically dependent continuant;vaccine conjugate role;role inheres in a material eneitity that union itself chemically with a relative weak vaccine antigen to form a new whole that can create an effective miinuogen. the 
specifically dependent continuant;licensed vaccine role;licensed vaccine role is a regulation-assigned role that indicates that a vaccine obtains official approval for commercial production and selling on the market.
specifically dependent continuant;effectiveness;effectiveness is physical quality that represents the capability of a single physical entity (e.g., vaccine) producing an effect (e.g, protection against a disease).
specifically dependent continuant;immunized;an organismal quality that indicates an organism (e.g., human) is immunized against a disease.
specifically dependent continuant;canada licensed veterinary vaccine role;a canada licensed vaccine role that indicates the vaccine is for veterinary uses.
specifically dependent continuant;vaccinated with a licensed vaccine;a vaccinated quality that indicates an organism is vaccinated with a licensed vaccine.
specifically dependent continuant;unimmunized;an organismal quality that indicates an organism (e.g., human) is not yet immunized against a disease.
specifically dependent continuant;tlr7 receptor role;a role of a material entity that binds to tlr7 and activates the receptor for pathogen recognition and activation of innate immunity.
specifically dependent continuant;recombinant viral vector vaccine role;a recombinant vector vaccine role that inheres in a virus that carries a vaccine antigen for development of a particular vaccine 
specifically dependent continuant;laboratory animal model of vaccine research;animal model of vaccine research is a role played by some organism (e.g., mouse) that is used for vaccine research in the laboratory.
specifically dependent continuant;vaccine organism live attenuated;a virulence of vaccine organism that shows an attenuated pheontype of the organism as the major component of a vaccine.
specifically dependent continuant;subunit vaccine role;a vaccine role that indicates the vaccine being a subunit vaccine. 
specifically dependent continuant;viral vaccine organism live attenuated;a live attenuated quality of a virus vaccine strain. 
specifically dependent continuant;whole organism vaccine role;a vaccine role that indicates the vaccine being a combination vaccine. 
specifically dependent continuant;vaccine in clinical trial role;vaccine in clinical trial role is a regulation-assigned role that inheres in a vaccine that is currently in clinical trial.
specifically dependent continuant;licensed human vaccine role;a licensed vaccine role that is bears in a licensed human vaccine.
specifically dependent continuant;vaccination frequency;vaccination frequency is a qualitative term that represents how many times vaccination has occurred.
specifically dependent continuant;toxoid vaccine role;a vaccine role that indicates the vaccine being a toxoid vaccine. 
specifically dependent continuant;preventive vaccine function;preventive vaccine function is a vaccine function realized by the process of vaccination and leading to induction of an adaptive immune response to the antigens in a vaccine, which protects against a specific disorder.
specifically dependent continuant;vaccine stabilizer role;a role inheres in vaccine component when added into vaccine's formulation, it tends to inhibit the reaction between two or more other vaccine substances in the final vaccine formulation. it also helps to protect the vaccine from adverse conditions such as the freeze-drying process or heat.
specifically dependent continuant;vaccine candidate role;vaccine candidate role is the role of a material entity in an investigation, which has not been experimentally or clinically verified to induce a protection or treatment in vivo in a host organism. 
specifically dependent continuant;recombinant vaccine vector role;a vaccine component role that inheres in a recombinant vaccine vector as a vaccine component. the combination of a recombinant vaccine vector and a heterogenous protective antigen(s) inserted inside the vector for a recombinant vector vaccine. 
specifically dependent continuant;usda licensed veterinary vaccine role;a usa licensed vaccine role that indicates the vaccine is for veterinary uses.
specifically dependent continuant;canada licensed vaccine role;a licensed status that occurs in canada.
generically dependent continuant;cfu reduction per spleen;a reduction of cfu that was measured with the unit of colony forming units (cfu) from the sample of mouse spleen.
generically dependent continuant;vaccination mouse strain datum;a measurement datum that represents a specific mouse strain used for vaccination. different strains can be represented using discretized digitals. for example, 0 = balb/c. 1 = cd1. 2 = mixed/outbred. 3 = c57bl/6. 4 = of1. 5 = 129/sv. 6 = swiss albino. 
generically dependent continuant;vaccine target specification;the objective that intends to produce vaccine via the vaccine preparation process.
generically dependent continuant;vaccine strain datum;a measurement datum that represents a vaccine strain. different strains can be represented using distinct digital numbers. 
generically dependent continuant;mutated gene in vaccine strain datum;a measurement datum that represents a specific mutated gene from a vaccine strain. the mutated can be represented by a described digit. 
generically dependent continuant;vaccine dose;vaccine dose is a dose of vaccine specified by the vaccine manufacturer, distributor, or a regulatory agent.
generically dependent continuant;vaccine investigation data set;a data set that represents a set of data for a list of variables (e.g., vaccination dose) for the data analysis of an vaccine investigation study.
generically dependent continuant;antibody titer;antibody titer is a titer of antibody that shows how much antibody an organism has produced that recognizes a particular epitope, expressed as the greatest dilution ratio (or its reciprocal) that still gives a positive result. elisa is a common means of determining antibody titers.
generically dependent continuant;vaccine viability datum;a measurement datum that represents vaccine viability. 0 = live. 1 = irradiated. 2 = killed.
generically dependent continuant;female biological sex datum;a biological sex datum that represents the biological sex of an animal (including human) as being female.
generically dependent continuant;biological sex datum;a measurement datum that represents the biological sex of an animal. the result can be represented using a discretized digit, for example, 0 = female. 1 = male.
generically dependent continuant;reduction of colony forming unit;reduction of colony-forming unit (cfu) is a titer measurement of viable bacterial or fungal numbers. it equals to a reduction of a cfu count from another cfu count. this term is often used as a measurement of a vaccine protection study.
generically dependent continuant;male biological sex datum;a biological sex datum that represents the biological sex of an animal (including human) as being male.
generically dependent continuant;vaccination dose (unit: cfu);a vaccination dose that is used with the unit of colony forming units (cfu).
generically dependent continuant;challenge dose (unit: cfu);a challenge dose that is represented with the unit of colony forming units (cfu).
generically dependent continuant;titer;a titer (or titre) is a measure of concentration. titer testing employs serial dilution to obtain approximate quantitative information from an analytical procedure that inherently only evaluates as positive or negative. the titer corresponds to the highest dilution factor that still yields a positive reading. for example, positive readings in the first 8 serial twofold dilutions translate into a titer of 1:256.
generically dependent continuant;vaccination coverage;a measure datum that measures the coverage of vaccination in a specific area during a specific time period.
generically dependent continuant;vaccination protocol;vaccination protocol is the protocol of a vaccination procedure.
generically dependent continuant;pathogen challenge protocol;pathogen challenge protocol is a protocol that is used for a pathogen challenge process.
generically dependent continuant;specification of vaccination-challenge interval;specification of time interval after vaccination for challenge is a plan specification that specifies the time interval after vacciation for challenge
generically dependent continuant;intersex biological sex datum;a biological sex datum that represents the biological sex of an animal (including human) as being intersex.
generically dependent continuant;pathogen strain for challenge datum;a measurement datum that represents a specific pathogen strain used for animal challenge study. different pathogen strains can be represented using discretized digitals. 
generically dependent continuant;vaccine effectiveness rate;vaccine effectiveness rate is a measurement datum that measues the vaccine effectiveness. it is assessed with respect to prevention of the disease against which the vaccine is given. one simple method to estimate vaccine effectiveness is to use routine data on notifications of disease cases in vaccinated and unvaccinatted children and to compare the porportion of cases vaccinated with the vaccine covervage among the same age group in the general population. if p is the proportion vaccinated in the population and c is the proportion of cases reported to be vaccinated, then ve = (p-c)/p(1-c) x 100%.
generically dependent continuant;vaccine related journal article;the jourmal article that mentions a vaccine, which was retrieved from pubmed and annotated using vo-sciminner.(hur j, xiang z, feldman el, he y. ontology-based brucella vaccine literature indexing and systematic analysis of gene-vaccine association network. bmc immunology. 12(1):49 2011 aug 26. pmid: 21871085.)
generically dependent continuant;challenge dose;challenge dose is a dose of a virulent pathogen used for a vaccine challenge process.
generically dependent continuant;cfu per spleen;a colony forming unit (cfu) from the sample of mouse spleen.
generically dependent continuant;pathogen challenge datum;a measurement datum that represents a specific pathogen used for animal challenge study. different pathogens can be represented using discretized digitals. 
generically dependent continuant;vaccine adjuvant usage datum;a measurement datum that indicates the usage of a vaccine adjuvant. different digital numbers can be used to represent different adjuvants. 
generically dependent continuant;vaccination route datum;a measurement datum that represents a specific route (e.g., i.p.) used for vaccination. different routes can be represented using discretized digitals. 0 = ip. 1 = po. 2 = sc. 3 = im. 4 = in. 6 = ig. 7 = iv. 8 = id. 
generically dependent continuant;vaccination-challenge interval in days;a measurement datum that represents a length of days as the interval between a vaccination and a challenge in a specific vaccine protection study. 
generically dependent continuant;vaccine protective antigen datum;a measurement datum that represents a specific protective antigen used in a vaccine. the antigen can be represented by a described digit. 
generically dependent continuant;immunization objective;immunization objective is the specification of an objective to achieve immunization.
generically dependent continuant;human age within one month at vaccination;the age with the range from the birth to one month after birth at when a vaccination is taken. hepb vaccination is sometimes taken within 12 hours after birth.
generically dependent continuant;animal age at vaccination in days;a measurement datum that represents the animal age (unit: day) at the time of vaccination.
generically dependent continuant;vaccine protection efficacy datum;a measurement datum that represents a type of vaccine protection efficacy as an outcome of a vaccine protection study. the result can be represented as a digit, for example, 0 = no protection, and 1 = protection (determined by a p-value cutoff).
process;vaccine storage;a storage process that is specifically for vaccine.
process;vaccine storage in freezer;vaccine storage that is executed in freezer under 0^c.
process;vaccine-induced t cell interferon-gramm production boosted by il-15 vaccine adjuvant;a vaccine-induced adjuvant boosted t cell interferon-gramm production that results from the addition of a il-15 vaccine adjuvant
process;vaccine storage in refrigerator;vaccine storage that is executed in refrigerator, usually 0-10^c.
process;vaccine protection efficacy measurement;vaccine protection efficacy measurement is an assay that measures the protection efficayc of a vaccine.
process;preparation of cancer vaccine;a vaccine preparation that results in the generation of a cancer vaccine
process;phase 2 vaccine trial;a vaccine clinical trial that studies vaccine efficacy with a target population (numbering 50-100). different dosage levels will also be explored at this stage to determine the optimum dose.
process;intravesical vaccination;the injection of a given substance directly into the bladder via a urethral catheter instead of being injected under the skin.
process;vaccine specific interferon- immune response;vaccine-induced t-helper 1 type immune response that is indicated by the presence of interferon-gamma production
process;active immunization;active immunization is an immunization process that entails the introduction of a foreign molecule into the body, which causes the body itself to generate adaptive immunity against the target.
process;primary vaccination;a vaccination process that occurs at the first time to a host organization in a specified period.
process;preparation of live attenuated vaccine by serial passages in vitro;a live attenuated vaccine prepraration process that is performed by serial passages in vitro for pathogen attenuation.
process;induction of adaptive immune response to antigen;induction of adaptive immune response to antigen is an active immunization process that results in induction of adaptive immune response to some antigens, for example, in a vaccine.
process;passive immunization by injecting pre-made immune element;passive immunization by injecting a recipient with pre-made antibody, antitoxin, epitope, etc.
process;subcutaneous vaccination;vaccination process that occurs in the subcutaneous route
process;intranasal vaccination;vaccination process that occurs in intranasal route
process;cfu reduction assay;cfu reduction assay is an assay that measures the reduction of the colony forming units of infected pathogens in vaccine-vaccinated animals compared to nonvaccinated animals.
process;quaternary vaccination;quaternary vaccination is a vaccination that is performed at the fourth time in a row.
process;host response to vaccine adjuvant;a process that specifies host response to a vaccine adjuvant.
process;subunit vaccine preparation;a vaccine preparation that results in the generation of a subunit vaccine
process;therapeutic vaccination;a vaccination process that involves adding a vaccine into a host after a disease has occurred.
process;th1/th2/th17 mixed immune profile;an immune profile that is characterized by the presense of type 1 type 2, and th17 t helper cells.
process;survival of live vaccine inside host;survival of live vaccine inside host is a processual entity that represents the survival of a live vaccine inside its host. the time of the survival is often important for the success of the live vaccine.
process;prophylactic vaccination;a vaccination process that involves adding a vaccine into a host prior to disease.
process;secondary vaccination;secondary vaccination is a vaccination that is performed immediately after the primary or the first vaccination.
process;natural active immunization;natural active immunization is an active immunization that occur naturally when a person or animal comes in contact with antigens includeing microbes.
process;allergy vaccine preparation;a vaccine preparation that results in the generation of a allergy vaccine
process;host response to vaccine antigen;a process that specifies host response to a vaccine antigen.
process;intragastric vaccination;vaccination that occurs in the intagastric route.
process;preparation of rna vaccine;a vaccine preparation that results in the generation of a rna vaccine
process;vaccine-induced host immune response;any immune system process that functions in the calibrated response of the host to a vaccine.
process;vaccine specific interleukin-10 response;vaccine-induced t-helper 2 type immune response that is indicated by the presence of interleukin-10 production
process;vaccine transportation;a processual entity of transporting vaccine from one place to another place.
process;intramuscular vaccination;a vaccination that occurs in the intramuscular route.
process;host response to vaccine component;a processual entity that specifies host response to a vaccine component.
process;phase 1 vaccine trial;a vaccine clinical trial that investigates the safety profile of a vaccine in a small group (10-50) of healthy volunteers.
process;review of vaccine license application;a vaccine regulatory process that is for vaccine regulatory agent to review vaccine license application from vaccine producer.
process;vaccine approval process;vaccine approval process is a processual entity that involves approval of a vaccine.
process;vaccine persistence assay;an assay that measures the persistent survival of live vaccine in a host in vivo.
process;host susceptibility gene response to vaccine adverse event;a vaccine-induced host gene response that represents a vaccine adverse event response associated with a host susceptibility gene.
process;vaccine immunization;artificial active immunization is an active immunization that occurs when a person or animal is vaccinated with a specific vaccine.
process;th1-biased immune profile;a biased immune profile that is characterized by the presense of t help cells type 1 t helper (th1) cells that produce interferon-gamma, interleukin (il)-2, and tumour necrosis factor (tnf)-beta, which activate macrophages and are responsible for cell-mediated immunity and phagocyte-dependent protective responses.
process;modification of adaptive immune response to antigen;modification of adaptive immune response to antigen is an active immunization process that results in modification of an adaptive immune response to some antigens, for example, in a therapeutic vaccine.
process;vaccine reconstitution;a vaccine prepration process that mixes vaccine lyophilized powder and diluent liquid. the process forms a vaccine that can be used for administration. this term can also be considered as a child term of obi term 'material combination'. 
process;vaccine-induced, adjuvant boosted t cell interferon-gramm production;a vaccine-induced t cell interferon-gramm production that results from the addition of a vaccine adjuvant
process;infection disorder prevention;infection disorder prevention is a process that prevents a disorder that is the physical basis of an infectious disease.
process;vaccine-induced herd immunity;when the vaccination of a significant portion of a population (or herd), in contagious diseases that are transmitted from individual to individual, chains of infection are likely to be disrupted, so the large numbers of a population are immue or less susceptible to the disease. 
process;immunization;immunization is a processual entity that primes or modifies an adaptivie immune response to some antigens.
process;disorder treatment;disorder treatment is a processual entity that leads to treat a disorder that is the physical basis of a disease.
process;vaccine specific il-2 immune response;vaccine-induced t-helper 1 type immune response that is indicated by the presence of interleukin-2 production
process;vaccine specific th2 immune response indicated by igg1 production;vaccine-induced t-helper 2 type immune response that is indicated by the presence of igg1 production
process;vaccine specific th1 immune response indicated by igg2a production;vaccine-induced t-helper 1 type immune response that is indicated by the presence of igg2a production
process;preparation of gene mutant vaccine;a live attenuated vaccine prepraration process that is performed by mutation of a gene(s) from a virulent pathogen.
process;preparation of vaccine using h2o2 inactivation;a vaccine prepraration process that is performed by h2o2 inactivation of virulent pathogen.
process;th17 immune profile;an immune profile that is characterized by the presense of t helper 17 cells (th17) that a subset of pro-inflammatory t helper cells defined by their production of interleukin 17 (il-17). they are related to t regulatory cells and the signals that cause th17s to differentiate actually inhibit treg differentiation.
process;intraperitoneal vaccination;a vaccination process that occurs in the intraperitoneal route
process;serologic correlate of protection;serological correlate of protection is an immune correlate of protection that is reflected by serologic antibody levels.
process;preparation of recombinant vector vaccine;a vaccine preparation that results in the generation of a recombinant vector vaccine
process;preparation of conjugate vaccine;a vaccine preparation that results in the generation of a conjugate vaccine
process;phase 4 vaccine trial;the final stage of vaccine clinical evaluation. phase iv occurs after a vaccine or therapy is licensed and is being used by large numbers of people. these studies are not always required or completed.
process;vaccine-induced humoral immune response;vaccine induced immue response mediated hrough a body fluid
process;th1/th17 mixed immune profile;an immune profile that is characterized by the presense of both type 1 and type 17 t helper (th1 and th17) cells.
process;assay of cfu reduction in lung;assay of cfu reduction in lung is a cfu reduction assay that is measured using the extracted lung as the tissue for isolation of infected pathogens.
process;vaccination;a process of administering substance in vivo that involves in adding a vaccine into a host (e.g., human) in vivo with the intent to invoke a protective or therapeutic adaptive immune response.
process;vaccine regulation;a processual entity that regulates vaccine-related processes, such as vaccine trial, vaccine license application.
process;bacterial vaccine preparation;a vaccine preparation that results in the generation of a bacterial vaccine
process;cfu measurement assay;cfu measurement assay is an assay that measures the colony forming unit (cfu) of a bacterium in a specific location (e.g., spleen of a mouse).
process;live attenuated vaccine preparation;a vaccine preparation that results in the generation of a live attenuated vaccine
process;disorder prevention;disorder prevention is a processual entity that prevents a disorder that is the physical basis of a disease.
process;intraperitoneal pathogen challenge;intraperitoneal pathogen challenge is a pathogen challenge process that occurs in the intraperitoneal site of a host.
process;vaccine trial regulation;a vaccine regulation process for vaccine clinical trials.
process;preparation of recombinant protein vaccine;a vaccine preparation process that uses recombinant molecular technology to prepare recombinant protein.
process;passive immunization using natural maternal antibody;passive immunization that immunity is transferred from mother to fetus through placental transfer of igg or colostral transfer of iga.
process;preparation of dna vaccine;a vaccine preparation that results in the generation of a dna vaccine
process;protozoan vaccine preparation;a vaccine preparation that results in the generation of a protozoan vaccine
process;preparation of vaccine using heat inactivation;a vaccine prepraration process that is performed by heat inactivation of virulent pathogen.
process;hemagglutination-inhibition assay;an immune response detection assay that detects specific antiviral antibodies in a test serum. the serum, usually a twofold dilution series, is mixed with a standard number, usually 4 to 8 ha units, of virus and incubated prior to the addition of a standard suspension of erythrocytes. the highest dilution of serum that inhibits hemagglutination is the hi titer of the serum. for example, influenza (ai) viruses agglutinate erythrocytes through the interaction of the virus surface glycoprotein, the hemagglutinin (ha), with receptors on the surface of the erythrocyte. inhibition of the agglutination reaction by ha subtype-specific antisera is the basis of the hemagglutination-inhibition (hi) assay.
process;live attenuated vaccine-induced down-regulated gene expression compared to infection with wild type pathogen;a vaccine-induced down-regulation gene expression that occurs in live attenuated vaccine and compared with the host system infected with live wild type virulent strain which is the parent strain of this live attenuated vaccine. 
process;phase 3 vaccine trial;a vaccine clinical trial that takes the trial to a large-scale safety and efficacy study in a relevant patient population, usually in excess of 3,000.
process;vaccine specific interleukin-4 response;vaccine-induced t-helper 2 type immune response that is indicated by the presence of interleukin-4 production
process;survival assessment;survival assessment is an assay that measures the occurence of death events in one or more organisms that are monitored over time.
process;vaccine saftey regulation;a vaccine regulation for vaccine safety.
process;assay of cfu reduction in spleen;assay of cfu reduction in spleen is a cfu reduction assay that is measured using the extracted spleen as the tissue for isolation of infected pathogens.
process;viral vaccine preparation;a vaccine preparation that results in the generation of a viral vaccine
process;vaccine-induced host response;a processual entity that specifies host response to a vaccine.
process;cell mediated immune correlate of protection;a cell mediated immune correlate of protection is an immune correlate of protection that is reflected by a cell mediated immune response.
process;assay of cfu reduction in liver;assay of cfu reduction in liver is a cfu reduction assay that is measured using the extracted liver as the tissue for isolation of infected pathogens.
process;vaccine preparation;vaccine preparation is a manufacturing process to produce a vaccine.
process;tertiary vaccination;tertiary vaccination is a vaccination that is performed at the third time in a row.
process;rapid vaccination;a vaccination process that is implemented fast.
process;augmented protection and cellular immunity using host protein as adjuvant;an vaccine-induced host response that shows augmented protection and cellular immunity after a host protein is used as adjuvant. 
process;passive immunization;passive immunization is an immunization process where pre-synthesized elements of the immune system are transferred to an organism so that the body does not need to produce these elements itself.
process;vaccine storage at room temperature;a vaccine storage that is execuated at room temperature. room temperature is also referred to as ambient temperature. room temperature denotes a certain temperature within enclosed space at which humans are accustomed. room temperature is usually indicated by general human comfort, with the common range of 10 degree c (50 degree f) to 28 degree c (82.4 degree f).
process;host response to vaccine vaccine vector;a process that specifies host response to a vaccine vector.
process;cancer vaccine preparation;a vaccine preparation that results in the generation of a cancer vaccine
process;preparation of toxoid vaccine;a vaccine preparation that results in the generation of a toxoid vaccine
process;inactivated vaccine preparation;a vaccine preparation that results in the generation of a inactivated vaccine
process;oral vaccination;vaccination process that occurs in oral route.
process;vaccine clinical trial;a processual entity by which a vaccine is tested clinically for safety and effectiveness. clinical trials are conducted in phases. classically, clinical trials unfold in three phases in order to gather data and information about a vaccine and its performance. this will form the basis of a dossier submitted to regulatory authorities by way of an application for licensure. after a vaccine is licensed and is being used by large numbers of people, a phase iv study may or may not be taken for vaccine clinical evaluation.
process;vaccine license application;a vaccine regulatory process that is for vaccine producer to apply for vaccine license.
process;live attenuated vaccine-induced up-regulated gene expression compared to infection with wild type pathogen;a vaccine-induced up-regulation gene expression that occurs in live attenuated vaccine and compared with the host system infected with live wild type virulent strain which is the parent strain of this live attenuated vaccine. 
process;th1/th2 mixed immune profile;an immune profile that is characterized by the presense of both type 1 and type 2 t helper (th1 and th2) cells.
process;th2-biased immune profile;a baised immune profile that is characterized by the presense of t type 2 th (th2) cells that produce il-4, il-5, il-10, and il-13, which are responsible for strong antibody production, eosinophil activation, and inhibition of several macrophage functions, thus providing phagocyte-independent protective responses.
process;fungal vaccine preparation;a vaccine preparation that results in the generation of a fungal vaccine
process;persistence of vaccine induced immune response;persistence of vaccine induced immune response is a processual entity that indicates the persistence of an immune reponse induced by a vaccine in a vaccinated host.
